Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jean-Louis Montastruc
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Disorders
Geographic Areas
Concepts & Ideas
Chemicals & Drugs
Procedures
Sign-in to see full Profile
Network (preview)
122
Rascol, Olivier
96
Senard, Jean-Michel
91
Lapeyre-Mestre, Maryse
74
Tran, Marie-Antoinette
60
Damase-Michel, Christine
51
Bagheri, Haleh
41
Berlan, Michel
29
Valet, Philippe
28
Brefel-Courbon, Christine
25
Verwaerde, Patrick
23
Pathak, Atul
23
Galinier, Michel
22
Sommet, Agnès
16
Sénard, Jean-Michel
16
Galitzky, Jean
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jean-Louis Montastruc (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Sommet Agnès; Shams Reza; Valnet-Rabier Marie-Blanche; Jean-Pastor Marie-Josèphe; Castot Anne; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
[Drugs and Heat Wave: SIRIUS, a Multicentric Case-Control Study in Patients Older than 65 Years During 2007 Summer in France.]
Thérapie 2009;64(5):295-301.
-
2009: Tavassoli Neda; Lapeyre-Mestre Maryse; Sommet Agnès; Montastruc Jean-Louis;
Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol).
British journal of clinical pharmacology 2009;68(3):422-6.
-
2009: Lacroix I; Hurault C; Sarramon M F; Guitard C; Berrebi A; Grau M; Albouy-Cossard C; Bourrel R; Elefant E; Montastruc J L; Damase-Michel C
Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database.
European journal of clinical pharmacology 2009;65(8):839-46.
-
2009: Tavassoli Neda; Montastruc Jean-Louis
Is there any relationship between actual benefit and added value of drugs and pharmacovigilance alerts?
British journal of clinical pharmacology 2009;68(1):124-5.
-
2009: Fuzier Régis; Lapeyre-Mestre Maryse; Mertes Paul-Michel; Nicolas Jean-François; Benoit Yves; Didier Alain; Albert Natalie; Montastruc Jean-Louis;
Immediate- and delayed-type allergic reactions to amide local anesthetics: clinical features and skin testing.
Pharmacoepidemiology and drug safety 2009;18(7):595-601.
-
2009: Pugnet Gregory; Ysebaert Loïc; Bagheri Haleh; Montastruc Jean-Louis; Laurent Guy
Immune thrombocytopenic purpura following human papillomavirus vaccination.
Vaccine 2009;27(28):3690.
-
2009: Burgan Franck; Montastruc Jean-Louis; Bagheri Haleh
[Dobesilate-induced serious neutropenia]
Presse médicale (Paris, France : 1983) 2009;38(5):846-8.
-
2009: Gaubert Sabine; Vié Martine; Damase-Michel Christine; Pathak Atul; Montastruc Jean-Louis
Dextropropoxyphene withdrawal from a French university hospital: impact on analgesic drug consumption.
Fundamental & clinical pharmacology 2009;23(2):247-52.
-
2009: Boeuf-Cazou O; Lapeyre-Mestre M; Niezborala M; Montastruc J L
Evolution of drug consumption in a sample of French workers since 1986: the 'Drugs and Work' study.
Pharmacoepidemiology and drug safety 2009;18(4):335-43.
-
2009: Bondon-Guitton E; Sommet A; Montastruc J L;
Confusion, a rather serious adverse drug reaction with valproic acid: a review of the French Pharmacovigilance database.
Pharmacopsychiatry 2009;42(2):61-5.
-
2009: Espinasse G; Kamar N; Hurault C; Suc B; Fourtanier G; Montastruc J L; Rostaing L; Bagheri H
Drug exposure and perceived adverse drug events reported by liver-transplant patients.
International journal of clinical pharmacology and therapeutics 2009;47(3):159-64.
-
2009: Sommet Agnès; Pathak Atul; Montastruc Jean-Louis
Tesofensine and weight loss.
Lancet 2009;373(9665):719; author reply 720.
-
2009: Montastruc Guillaume; Degand Bruno; Montastruc Jean-Louis; Perault-Pochat Marie-Christine
[Cardiac arrest with varenicline: a case report]
Thérapie 2009;64(1):65-6.
-
2009: Décisier M; Duhalde V; Faure P; Ammoury A; Gony M; Moreau J; Montastruc J L; Bagheri H
Rapid-onset febrile dermatosis.
Gut 2009;58(1):67, 125.
-
2009: Sommet Agnès; Castot Anne; Montastruc Jean-Louis
Heat waves and the elderly. Adverse drug events.
BMJ (Clinical research ed.) 2009;339():b3146.
-
2009: Olivier Pascale; Bertrand Lionel; Tubery Marie; Lauque Dominique; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey.
Drugs & aging 2009;26(6):475-82.
-
2009: Do Catherine; Huyghe Eric; Lapeyre-Mestre Maryse; Montastruc Jean Louis; Bagheri Haleh
Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(7):591-7.
-
2009: Fuzier Régis; Lapeyre-Mestre Maryse; Samii Kamran; Montastruc Jean-Louis;
Adverse drug reactions to local anaesthetics: a review of the French pharmacovigilance database.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(4):345-56.
-
2008: Tavassoli Neda; Montastruc-Fournier Julie; Montastruc Jean Louis;
Psychiatric adverse drug reactions to glucocorticoids in children and adolescents: a much higher risk with elevated doses.
British journal of clinical pharmacology 2008;66(4):566-7.
-
2008: Molokhia Mariam; Pathak Atul; Lapeyre-Mestre Maryse; Caturla Laetitia; Montastruc Jean Louis; McKeigue Paul
Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France.
British journal of clinical pharmacology 2008;66(3):386-95.
-
2008: Gallini Adeline; Sommet Agnès; Montastruc Jean-Louis;
Does memantine induce bradycardia? A study in the French PharmacoVigilance Database.
Pharmacoepidemiology and drug safety 2008;17(9):877-81.
-
2008: Sommet A; Grolleau S; Bagheri H; Lapeyre-Mestre M; Montastruc J L;
Was the thrombotic risk of rofecoxib predictable from the French Pharmacovigilance Database before 30 September 2004?
European journal of clinical pharmacology 2008;64(8):829-34.
-
2008: Sailler Laurent; Attane Camille; Michenot Fleur; Canonge Jean-Marie; Rostaing Lionel; Arlet-Suau Elizabeth; Arlet Philippe; Launay François; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey.
British journal of clinical pharmacology 2008;66(2):320-2.
-
2008: Durrieu Geneviève; Lacroix Isabelle; Olivier Pascale; Sommet Agnès; Sénard Jean-Michel; Montastruc Jean-Louis;
[Drug-related neuropathies: analysis of the French Adverse Drug Reaction Database 1995-2005]
Presse médicale (Paris, France : 1983) 2008;37(6 Pt 1):935-42.
-
2008: Bürki Franck; Badie Kattalin; Bartoli Philippe; Bernard Pascale; Montastruc Jean Louis; Bagheri Haleh
Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen.
British journal of clinical pharmacology 2008;65(5):793-4.
-
2008: Hurault Caroline; Lacroix Isabelle; Bourrel Robert; Montastruc Jean-Louis; Damase-Michel Christine
[Writing and dispensing of NSAID prescriptions in late pregnancy: impact of health authorities' advice]
Presse médicale (Paris, France : 1983) 2008;37(5 Pt 1):767-74.
-
2008: Sailler L; Pereira C; Bagheri A; Uro-Coste E; Roussel B; Adoue D; Fournie B; Laroche M; Zabraniecki L; Cintas P; Arlet P; Lapeyre-Mestre M; Montastruc J L;
Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study.
Annals of the rheumatic diseases 2008;67(5):614-9.
-
2008: Fontanel Fabien; Durrieu Geneviève; Damase-Michel Christine; Montastruc Jean-Louis
[Drug prescription and pharmacovigilance in spa therapy: a comparative study at a 20-year interval (1987 versus 2007)]
Thérapie 2008;63(2):135-40.
-
2008: Sommet Agnès; Bagheri Haleh; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
Did thirst-blockers contribute to the exorbitant number of fatalities during the French 2003 heat wave?
Pharmacoepidemiology and drug safety 2008;17(3):312-3.
-
2008: Montastruc Jean-Louis; Lugardon Stéphanie; Desboeuf Karine; Fernet Pierre; Lapeyre-Mestre Maryse
[Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital]
Bulletin de l'Académie nationale de médecine 2008;192(2):421-30; discussion 430-1.
-
2007: Berthet Stéphanie; Grolleau Sabrina; Brefel-Courbon Christine; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
[Prevalence of diabetes in france and drug use: study based on the French pharmacovigilance database]
Thérapie 2007;62(6):483-8.
-
2007: Durrieu G; Olivier P; Bagheri H; Montastruc J L;
Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
Fundamental & clinical pharmacology 2007;21(5):555-8.
-
2007: Roussin Anne; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature.
Fundamental & clinical pharmacology 2007;21(5):459-66.
-
2007: Gallini Adeline; Sommet Agnès; Salandini Anne-Marie; Veyssière Patrick; Montastruc Jean-Louis; Montastruc Jean-Louis
Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(13):1980-1.
-
2007: Gallini Adeline; Sommet Agnès; Salandini Anne-Marie; Veyssière Patrick; Montastruc Jean-Louis; Montastruc Jean-Louis
Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(13):1980-1.
-
2007: Lacroix Isabelle; Cabou Cendrine; Montastruc Jean-Louis; Damase-Michel Christine
[Adverse drug reactions in pregnant women]
Thérapie 2007;62(5):455-60.
-
2007: Lugardon S; Roussel H; Sciortino V; Montastruc J L; Lapeyre-Mestre M
Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database.
European journal of clinical pharmacology 2007;63(8):801-7.
-
2007: Durrieu G; Hurault C; Bongard V; Damase-Michel C; Montastruc J L
Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course.
British journal of clinical pharmacology 2007;64(2):233-6.
-
2007: Brefel-Courbon Christine; Payoux Pierre; Ory Fabierine; Sommet Agnes; Slaoui Tarik; Raboyeau Gaelle; Lemesle Beatrice; Puel Michele; Montastruc Jean-Louis; Demonet Jean-Francois; Cardebat Dominique
Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy.
Annals of neurology 2007;62(1):102-5.
-
2007: Sailler Laurent; Puissant Bénédicte; Méliani Pascal; Castex Jean Olivier; Saivin Sylvie; Adoue D; Fournie B; Arlet Philippe; Montastruc Jean-Louis; Lapeyre-Mestre Maryse; Pourrat Jacques; Blancher Antoine
Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients.
Annals of the New York Academy of Sciences 2007;1108():41-50.
-
2007: Biga Julie; Gony Mireille; Bourrel Robert; Souche Arnaud; Sommet Agnès; Pathak Atul; Sciortino Vincent; Taboulet Florence; Grand Alain; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
Coxibs: evolution of prescription's behaviour in France.
Fundamental & clinical pharmacology 2007;21(3):317-25.
-
2007: Lacroix Isabelle; Hurault Caroline; Saivin Sylvie; Raoul Valérie; Berrebi Alain; Souchet Emmanuelle; Desboeuf Karine; Montastruc Jean-Louis; Damase-Michel Christine
[Prenatal exposure to psychoactive substances: results of NENUPHAR study]
Thérapie 2007;62(2):177-83.
-
2007: Gardette Virginie; Vezzosi Delphine; Maiza Jean-Christophe; Montastruc Jean-Louis; Olivier Pascale
Gynecomastia associated with fenofibrate.
The Annals of pharmacotherapy 2007;41(3):508-10.
-
2007: Tavassoli N; Duchayne E; Sadaba B; Desboeuf K; Sommet A; Lapeyre-Mestre M; Muoz M J; Sie P; Honorato J; Montastruc J L; Bagheri H
Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals.
European journal of clinical pharmacology 2007;63(3):221-8.
-
2007: Jourdan Géraldine; Verwaerde Patrick; Pathak Atul; Tran Marie-Antoinette; Montastruc Jean-Louis; Senard Jean-Michel
In vivo pharmacodynamic interactions between two drugs used in orthostatic hypotension--midodrine and dihydroergotamine.
Fundamental & clinical pharmacology 2007;21(1):45-53.
-
2007: Rascol Olivier; Slaoui Tarik; Regragui Wafa; Ory-Magne Fabiene; Brefel-Courbon Christine; Montastruc Jean-Louis
Dopamine agonists.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;84():73-92.
-
2007: Leclerc-Foucras Sophie; Bagheri Haleh; Samii Kamran; Montastruc Jean-Louis; Lapeyre-Mestre Maryse;
Modifications of low-molecular weight heparin use in a French university hospital after implementation of new guidelines.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(5):409-17.
-
2007: Sommet Agnès; Desplas Maryline; Lapeyre-Mestre Maryse; Montastruc Jean-Louis;
Drug-induced yawning: a review of the French pharmacovigilance database.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(4):327-31.
-
2006: Montastruc Jean-Louis; Sommet Agnès; Lacroix Isabelle; Olivier Pascale; Durrieu Geneviève; Damase-Michel Christine; Lapeyre-Mestre Maryse; Bagheri Haleh
Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.
Joint, bone, spine : revue du rhumatisme 2006;73(6):629-32.
-
2006: Noize P; Sauer M; Bruneval P; Moreau M; Pathak A; Bagheri H; Montastruc J L
Valvular heart disease in a patient taking benfluorex.
Fundamental & clinical pharmacology 2006;20(6):577-8.
-
2006: Olivier Pascale; Montastruc Jean-Louis
The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
Pharmacoepidemiology and drug safety 2006;15(11):808-12.
-
2006: Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc J L;
Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
Pharmacoepidemiology and drug safety 2006;15(10):735-40.
-
2006: Brefel-Courbon C; Gardette V; Ory F; Montastruc J L
Drug-induced myoclonus: a French pharmacovigilance database study.
Neurophysiologie clinique = Clinical neurophysiology 2006;36(5-6):333-6.
-
2006: Lapeyre-Mestre Maryse; de Castro Ana Maria Rueda; Bareille Marie-Pierre; Del Pozo Javier Garcia; Requejo Ana Alvarez; Arias Louis Martin; Montastruc Jean-Louis; Carvajal Alfonso
Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems.
Fundamental & clinical pharmacology 2006;20(4):391-5.
-
2006: Lugardon Stephanie; Desboeuf Karine; Fernet Pierre; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
British journal of clinical pharmacology 2006;62(2):225-31.
-
2006: Roussin A; Mirepoix M; Lassabe G; Dumestre-Toulet V; Gardette V; Montastruc J-L; Lapeyre-Mestre M
Death related to a recreational abuse of propofol at therapeutic dose range.
British journal of anaesthesia 2006;97(2):268.
-
2006: Guitton E; Barange K; Bagheri H; Montastruc J L; Vinel J P; Claeyssens S; Bonnet E; Massip P
Blood transaminase elevation with pegylated interferon alfa 2b plus ribavirin in an HIV/HCV coinfected haemophilic patient.
Infection 2006;34(3):183-5.
-
2006: Baudrant Magalie; Bagheri Haleh; Cuzin Lise; Sommet Agnès; Bassoua Valérie; Guitton Emmanuelle; Bonnet Eric; Garipuy Daniel; Lucas Françoise; Aquilina Christian; Montastruc Jean-Louis; Massip Patrice
[Analysis of antiretroviral drugs-induced adverse effects]
Thérapie 2006;61(2):171-6.
-
2006: Lugardon Stéphanie; Roussel Henri; Bourrel Robert; Sciortino Vincent; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
[Patterns of non steroidal anti-inflammatory drug use in ambulatory care]
Thérapie 2006;61(2):109-14.
-
2006: Desboeuf Karine; Grau Maryse; Riche Françoise; Fradin Marc; Bez Jacques; Montastruc Jean-Louis; Senard Jean-Michel
Prevalence and costs of parkinsonian syndromes associated with orthostatic hypotension.
Thérapie 2006;61(2):93-9.
-
2006: Ferreira J J; Desboeuf K; Galitzky M; Thalamas C; Brefel-Courbon C; Fabre N; Senard J-M; Montastruc J-L; Sampaio C; Rascol O
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(3):209-14.
-
2006: Guitton Emmanuelle; Montastruc Jean-Louis; Lapeyre-Mestre Maryse;
Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients.
European journal of clinical pharmacology 2006;62(3):243-9.
-
2006: Tavassoli Neda; Bagheri Haleh; Sommet Agnes; Delpierre Cyrille; Marion-Latard Fabrice; Massip Patrice; Aquilina Christian; Bonnet Eric; Obadia Martine; Labau Eric; Montastruc Jean Louis; Bernard Jacques
Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
Pharmacotherapy 2006;26(2):154-61.
-
2006: Montastruc Jean-Louis; Sommet Agnès; Olivier Pascale; Bagheri Haleh; Gony Mireille; Lapeyre-Mestre Maryse; Brefel-Courbon Christine; Ferreira Joachim; Schmitt Laurent; Senard Jean-Michel; Rascol Olivier
[Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]
Thérapie 2006;61(1):29-38.
-
2006: Cabou C; Lacroix I; Roncalli J; Elbaz M; Caillaux D; Damase-Michel C; Fauvel J M; Montastruc J L
[Myocardial infarction in a young female smoker taking oral contraception]
Archives des maladies du coeur et des vaisseaux 2006;99(1):80-5.
-
2006: Carvajal Alfonso; Macias Diego; Sáinz María; Ortega Sara; Martín Arias Luis H; Velasco Alfonso; Bagheri Haleh; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
HMG CoA reductase inhibitors and impotence: two case series from the Spanish and French drug monitoring systems.
Drug safety : an international journal of medical toxicology and drug experience 2006;29(2):143-9.
-
2005: Brefel-Courbon Christine; Payoux Pierre; Thalamas Claire; Ory Fabienne; Quelven Isabelle; Chollet François; Montastruc Jean Louis; Rascol Olivier
Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
Movement disorders : official journal of the Movement Disorder Society 2005;20(12):1557-63.
-
2005: Bagheri Haleh; Treil Antoine; Sailler Laurent; Mesplé Geneviève; Arlet Philippe; Montastruc Jean-Louis
[Reevaluation of causality assessment of adverse drug reactions reported in internal medicine]
Thérapie 2005;60(6):589-90.
-
2005: Sommet Agnès; Juillard-Condat Blandine; Cestac Philippe; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
[Methods for the measurement of drug consumption: application to antibiotics]
Thérapie 2005;60(6):553-9.
-
2005: Vellas B; Gauthier S; Allain H; Andrieu S; Aquino J-P; Berrut G; Berthel M; Blanchard F; Camus V; Dartigues J F; Dubois B; Forette F; Franco A; Gonthier R; Grand A; Hervy M P; Jeandel C; Joel M E; Jouanny P; Lebert F; Michot P; Montastruc J L; Nourhashemi F; Ousset P J; Pariente J; Rigaud A S; Robert P; Ruault G; Strubel D; Touchon J; Verny M; Vetel J M;
[Consensus statement on severe dementia]
Presse médicale (Paris, France : 1983) 2005;34(20 Pt 1):1545-55.
-
2005: Tavassoli Neda; Bagheri Haleh; Sailler Laurent; Benkemoun Philippe; Montastruc Jean-Louis; Arlet Philippe
Estimation of time devoted to adverse drug reactions assessment in an internal medicine department.
British journal of clinical pharmacology 2005;60(4):452-3.
-
2005: Damagnez Michel; Magnouat André; Niezborala Jacques; Laroze Michel; Gaston Jean-Charles; Montastruc Jean-Louis
[Drugs contraindicated in children: a study of drug prescriptions in ambulatory medicine in the south of France (Aude Department)]
Thérapie 2005;60(5):507-13.
-
2005: Vellas B; Gauthier S; Allain H; Andrieu S; Aquino J-P; Berrut G; Berthel M; Blanchard F; Camus V; Dartigues J-F; Dubois B; Forette F; Franco A; Gonthier R; Grand A; Hervy M-P; Jeandel C; Joel M-E; Jouanny P; Lebert F; Michot P; Montastruc J-L; Nourhashemi F; Ousset P-J; Pariente J; Rigaud A-S; Robert P; Ruault G; Strubel D; Touchon J; Verny M; Vetel J-M;
[Consensus statement on severe dementia]
Revue neurologique 2005;161(8-9):868-77.
-
2005: Vellas B; Gauthier S; Allain H; Andrieu S; Aquino J P; Berrut G; Berthel M; Blanchard F; Camus V; Dartigues J F; Dubois B; Forette F; Franco A; Gonthier R; Grand A; Hervy M P; Jeandel C; Joel M E; Jouanny P; Lebert F; Michot P; Montastruc J L; Nourhashemi F; Ousset P J; Pariente J; Rigaud A S; Robert P; Ruault G; Strubel D; Touchon J; Verny M; Vetel J M
Consensus statement on dementia of Alzheimer type in the severe stage.
The journal of nutrition, health & aging 2005;9(5):330-8.
-
2005: Tournamille Jean-François; Rigal-Huguet Françoise; Pathak Atul; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
[Cardiac effects of cytokines produced after rituximab infusion]
Bulletin du cancer 2005;92(9):769-71.
-
2005: Durrieu G; Olivier P; Montastruc J L;
COX-2 inhibitors and arterial hypertension: an analysis of spontaneous case reports in the Pharmacovigilance database.
European journal of clinical pharmacology 2005;61(8):611-4.
-
2005: Pathak Atul; Lapeyre-Mestre Maryse; Montastruc Jean-Louis; Senard Jean-Michel
Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure.
Movement disorders : official journal of the Movement Disorder Society 2005;20(9):1213-9.
-
2005: Sommet Agnès; Azaïs-Vuillemin Cécile; Bagheri Haleh; Rascol Olivier; Montastruc Jean Louis
Trimetazidine: a new cause for drug-induced parkinsonism?
Movement disorders : official journal of the Movement Disorder Society 2005;20(8):1080-1.
-
2005: Biga Julie; Taboulet Florence; Lapeyre-Mestre Maryse; Duguet Anne-Marie; Vincent Sciortino; Montastruc Jean-Louis
[Prescribing drugs by international non-proprietary name: the perception of health and non-health professionals]
Thérapie 2005;60(4):401-7.
-
2005: Pathak Atul; Raoul Valérie; Montastruc Jean-Louis; Senard Jean-Michel
Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France.
European journal of clinical pharmacology 2005;61(5-6):471-4.
-
2005: Mbongue T B Ngoundo; Sommet A; Pathak A; Montastruc J L
"Medicamentation" of society, non-diseases and non-medications: a point of view from social pharmacology.
European journal of clinical pharmacology 2005;61(4):309-13.
-
2005: Bagheri Haleh; Gony Mireille; Montastruc Jean-Louis
[Meningococcal serogroup C vaccine: a pharmacovigilance point of view]
Thérapie 2005;60(3):287-94.
-
2005: Biga Julie; Vigreux Philippe; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
[Muscular pain and hypolipidaemic drugs: a cross-sectional study in cardiological outpatient practice]
Thérapie 2005;60(3):295-7.
-
2005: Montastruc Jean-Louis; Bagheri Haleh; Lacroix Isabelle; Olivier Pascale; Durrieu Genevieve; Damase-Michel Christine; Lapeyre-Mestre Maryse
[New methods for studying drug associated risk: experience of the Toulouse Regional Pharmacovigilance Center]
Bulletin de l'Académie nationale de médecine 2005;189(3):493-502; discussion 502-5.
-
2005: Pathak Atul; Curnier Daniel; Fourcade Joëlle; Roncalli Jérôme; Stein Phyllis K; Hermant Patricia; Bousquet Marc; Massabuau Pierre; Sénard Jean-Michel; Montastruc Jean-Louis; Galinier Michel
QT dynamicity: a prognostic factor for sudden cardiac death in chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(2):269-75.
-
2005: Pathak A; Smih F; Galinier M; Verwaerde P; Rouet P; Philip-Couderc P; Montastruc J L; Senard J M
Insulin downregulates M(2)-muscarinic receptors in adult rat atrial cardiomyocytes: a link between obesity and cardiovascular complications.
International journal of obesity (2005) 2005;29(2):176-82.
-
2005: Ngoundo-Mbongue T B; Niezborala M; Sulem P; Briant-Vincens D; Bancarel Y; Jansou P; Chastan E; Montastruc J L; Lapeyre-Mestre M
Psychoactive drug consumption: performance-enhancing behaviour and pharmacodependence in workers.
Pharmacoepidemiology and drug safety 2005;14(2):81-9.
-
2005: Olivier Pascale; Caron Jacques; Haramburu Françoise; Imbs Jean-Louis; Jonville-Béra Annie-Pierre; Lagier Georges; Sgro Catherine; Vial Thierry; Montastruc Jean-Louis; Lapeyr-Mestre Maryse
[Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale]
Thérapie 2005;60(1):39-45.
-
2005: Souchet Emmanuelle; Lapeyre-Mestre Maryse; Montastruc Jean-Louis
Drug related falls: a study in the French Pharmacovigilance database.
Pharmacoepidemiology and drug safety 2005;14(1):11-6.
-
2004: Rascol Olivier; Pathak Atul; Bagheri Haleh; Montastruc J-L
Dopaminagonists and fibrotic valvular heart disease: further considerations.
Movement disorders : official journal of the Movement Disorder Society 2004;19(12):1524-5.
-
2004: Lapeyre-Mestre Maryse; Sulem Patrick; Niezborala Michel; Ngoundo-Mbongue Théodore Bienvenu; Briand-Vincens Dominique; Jansou Pierre; Bancarel Yannick; Chastan Evelyne; Montastruc Jean-Louis
[Taking drugs in the working environment: a study in a sample of 2106 workers in the Toulouse metropolitan area]
Thérapie 2004;59(6):615-23.
-
2004: Bagheri Haleh; Fouladi Atoussa; Barange Karl; Lapeyre-Mestre Maryse; Payen Jean-Louis; Montastruc Jean Louis; Vinel Jean-Pierre
Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy.
Pharmacotherapy 2004;24(11):1546-53.
-
2004: Lugardon S; Lapeyre-Mestre M; Montastruc J L
Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database.
European journal of clinical pharmacology 2004;60(9):673-7.
-
2004: Damase-Michel Christine; Vié Céline; Lacroix Isabelle; Lapeyre-Mestre Maryse; Montastruc J L
Drug counselling in pregnancy: an opinion survey of French community pharmacists.
Pharmacoepidemiology and drug safety 2004;13(10):711-5.
-
2004: Pathak Atul; Debats Pascaline; Galinier Michel; Montastruc Jean-Louis; Senard Jean-Michel
Intestinal obstruction associated with oral midodrine.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2004;14(3):202-3.
-
2004: Pathak A; Senard J M; Bujaud T; Bagheri H; Lapeyre-Mestre M; Tressieres M C; Montastruc J L
Medication error caused by confusing drug blisters.
Lancet 2004;363(9427):2142.
-
2004: Rascol Olivier; Pathak Atul; Bagheri Haleh; Montastruc Jean-Louis
New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance.
Movement disorders : official journal of the Movement Disorder Society 2004;19(6):611-3.
-
2004: Dugué A; Bagheri H; Lapeyre-Mestre M; Tournamille J F; Sailler L; Dedieu G; Salvayre R; Thouvenot J P; Massip P; Montastruc J L
Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals.
European journal of clinical pharmacology 2004;60(4):285-92.
-
2004: Lacroix I; Lapeyre-Mestre M; Bagheri H; Pathak A; Montastruc J L;
Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care.
Fundamental & clinical pharmacology 2004;18(2):201-6.
-
2004: Montastruc Jean-Louis; Lapeyre-Mestre Maryse; Gony Mireille; Lugardon Stephanie; Bagheri Haleh
[Coxibs, which real therapeutic advance?: Recent pharmacoepidemiological data]
Thérapie 2004;59(2):201-5.
-
2004: Bagheri Haleh; Simiand Elise; Montastruc Jean-Louis; Magnaval Jean-François
Adverse drug reactions to anthelmintics.
The Annals of pharmacotherapy 2004;38(3):383-8.
-
2004: Lacroix I; Berrebi A; Chaumerliac C; Lapeyre-Mestre M; Montastruc J L; Damase-Michel C
Buprenorphine in pregnant opioid-dependent women: first results of a prospective study.
Addiction (Abingdon, England) 2004;99(2):209-14.
-
2004: Lapeyre-Mestre Maryse; Gregoire Nicolas; Bugat Roland; Montastruc Jean-Louis
Vinorelbine-related cardiac events: a meta-analysis of randomized clinical trials.
Fundamental & clinical pharmacology 2004;18(1):97-105.
-
2004: Montastruc Jean-Louis; Durrieu Geneviève
[Drug-induced tremor and acute movement disorders]
Thérapie 2004;59(1):97-103.
-
2004: Durrieu Geneviève; Gorsse Elisabeth; Montastruc Jean-Louis
[Are newspapers a reliable source of information about doping in sports?]
Thérapie 2004;59(1):89-91.
-
2004: Nguyen Nhan; Pradel Vincent; Micallef Joëlle; Montastruc Jean-Louis; Blin Olivier
[Drug-induced parkinson syndromes]
Thérapie 2004;59(1):105-12.
-
2004: Montastruc J L; Pathak A; Bagheri H
[Pergolide treatment and cardiac valve pathology: the continuing saga of ergotamine-induced fibrosis]
Revue neurologique 2004;160(1):19-21.
-
2004: Bracco Fulvio; Battaglia Angelo; Chouza Carlos; Dupont Erik; Gershanik Oscar; Marti Masso Jose Felix; Montastruc Jean-Louis;
The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
CNS drugs 2004;18(11):733-46.
-
2003: Lapeyre-Mestre M; Llau M-E; Gony M; Navel A-M; Bez J; Grau M; Montastruc J-L
Opiate maintenance with buprenorphine in ambulatory care: a 24-week follow-up study of new users.
Drug and alcohol dependence 2003;72(3):297-303.
-
2003: Delga Catherine; Megnin Yves; Oustric Stéphane; Laurent Christian; Pauly Laurent; Vergez Jean-Pierre; Charlet Jean-Paul; Montastruc Jean-Louis; Arlet Philippe
[A pilot study in general practice: pressure to prescribe]
Thérapie 2003;58(6):513-7.
-
2003: Chabrol Henri; Niezborala Michel; Chastan Evelyne; Montastruc Jean Louis; Mullet Etienne
A study of the psychometric properties of the Fagestrom Test for Nicotine Dependence.
Addictive behaviors 2003;28(8):1441-5.
-
2003: el Mahou Soumaya; Vaugeois Alice; Jouan Anne; Madaule Serge; Sailler Laurent; Ollier Sylvie; Joffre Francis; Bagheri Haleh; Montastruc Jean-Louis; Arlet Philippe
[Generalized angioedema with capillary leak syndrome after piroxicam use: a case]
Thérapie 2003;58(5):465-7.
-
2003: Cabou Cendrine; Bagheri Haleh; Cantagrel Alain; Mazières Bernard; Montastruc Jean-Louis
[Retrospective analysis of adverse effects of infliximab in a hospital rheumatology service]
Thérapie 2003;58(5):457-62.
-
2003: Courbon Frédéric; Brefel-Courbon Christine; Thalamas Claire; Alibelli Marie-Jeanne; Berry Isabelle; Montastruc Jean-Louis; Rascol Olivier; Senard Jean-Michel
Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2003;18(8):890-7.
-
2003: Pathak Atul; Léger Philippe; Bagheri Haleh; Senard Jean-Michel; Boccalon Henri; Montastruc Jean-Louis
Garlic interaction with fluindione: a case report.
Thérapie 2003;58(4):380-1.
-
2003: Belhadj-Tahar Hafid; Nassar Bertrand; Coulais Yvon; Montastruc Jean-Louis; Sadeg Nouredine
Acute pseudo-aldosteronism syndrome induced by liquorice.
Thérapie 2003;58(4):375-8.
-
2003: Oscar Marie-Annick; Bataillon Cécile; Bagheri Haleh; Le Quellec Anne; Rolland Françoise; Montastruc Jean-Louis
[Acamprosate (Aotal): could adverse effects upset the treatment of alcohol dependence?]
Thérapie 2003;58(4):371-4.
-
2003: Olivier Pascale; Dugué Aurelie; Montastruc Jean-Louis
[Adverse cardiovascular and central neurologic reactions to sympathomimetics used as nasal decongestants: results of the French National Pharmacovigilance Survey]
Thérapie 2003;58(4):361-6.
-
2003: Buys Sophie; Smih Fatima; Pathak Atul; Philip-Couderc Pierre; Verwaerde Patrick; Montastruc Jean-Louis; Rouet Philippe; Senard Jean-Michel
Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell line.
British journal of pharmacology 2003;139(6):1219-27.
-
2003: Gony Mireille; Lapeyre-Mestre Maryse; Montastruc Jean-Louis;
Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs.
Clinical neuropharmacology 2003;26(3):142-5.
-
2003: Brefel-Courbon Christine; Desboeuf Karine; Thalamas Claire; Galitzky Monique; Senard Jean-Michel; Rascol Olivier; Montastruc Jean-Louis
Clinical and economic analysis of spa therapy in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2003;18(5):578-84.
-
2003: Montastruc J-L; Schmitt L; Bagheri H
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine]
Revue neurologique 2003;159(4):441-3.
-
2003: Roussel-Navarro Véronique; Bagheri Halah; Montastruc Jean-Louis; Taillefer Gilbert; Bez Jacques; Lapeyre-Mestre Maryse
[Economic impact of generic substitution in the southwest of France: study of prescription and delivery of generic drugs based on Caisse Primaire d'Assurance Maladie de la Haute-Garonne data ]
Thérapie 2003;58(2):175-7.
-
2003: Cabou Cendrine; Lacroix Isabelle; Rista Cristina; Rolland Michel; Chassaing Nicolas; Calvas Patrick; Montastruc Jean-Louis; Damase-Michel Christine
[Finger agenesis after in utero exposure to ketoconazole: a case report]
Thérapie 2003;58(2):172-4.
-
2003: Montastruc Jean-Louis; Arnaud Philippe; Barbier Catherine; Berlin Ivan; Gatignol Chantal; Haramburu Françoise; Lagier Georges; Lapeyre-Mestre Maryse; Mallaret Michel; Micaleff Joëlle
[Pharmacologic criteria for medical substitution in opiate dependence]
Thérapie 2003;58(2):123-5.
-
2003: Fénelon G; Giménez-Roldán S; Montastruc J L; Bermejo F; Durif F; Bourdeix I; Péré J-J; Galiano L; Schadrack J
Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(3):239-51.
-
2003: Angles Anne; Bagheri Haleh; Montastruc Jean-Louis; Magnaval Jean-François;
[Adverse drug reactions (ADRs) to antimalarial drugs. Analysis of spontaneous report from the French pharmacovigilance database (1996-2000)]
Presse médicale (Paris, France : 1983) 2003;32(3):106-13.
-
2003: Pelat Michel; Verwaerde Patrick; Galitzky Jean; Lafontan Max; Berlan Michel; Senard Jean-Michel; Montastruc Jean-Louis
High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
The Journal of pharmacology and experimental therapeutics 2003;304(1):246-53.
-
2003: Rascol Olivier; Payoux Pierre; Ory Fabienne; Ferreira Joaquim J; Brefel-Courbon Christine; Montastruc Jean-Louis
Limitations of current Parkinson's disease therapy.
Annals of neurology 2003;53 Suppl 3():S3-12; discussion S12-5.
-
2003: Cestac Philippe; Bagheri Haleh; Lapeyre-Mestre Maryse; Sié Pierre; Fouladi Atoussa; Maupas Eric; Léger Philippe; Fontan Bernard; Massip Patrice; Montastruc Jean-Louis
Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients.
Drug safety : an international journal of medical toxicology and drug experience 2003;26(3):197-207.
-
2002: Rascol O; Ferreira J J; Payoux P; Brefel-Courbon Ch; Montastruc J L
[Management of levodopa-induced dyskinesia]
Revue neurologique 2002;158 Spec no 1():S117-24.
-
2002: Horen Benjamin; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Adverse drug reactions and off-label drug use in paediatric outpatients.
British journal of clinical pharmacology 2002;54(6):665-70.
-
2002: Montastruc Jean-Louis; Lapeyre-Mestre Maryse; Bagheri Haleh; Fooladi Atoussa
Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France.
Fundamental & clinical pharmacology 2002;16(5):343-6.
-
2002: Bongard V; Ménard-Taché S; Bagheri H; Kabiri K; Lapeyre-Mestre M; Montastruc J L
Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals.
British journal of clinical pharmacology 2002;54(4):433-6.
-
2002: Montastruc J L
[Social pharmacology: a new topic in clinical pharmacology]
Thérapie 2002;57(5):420-6.
-
2002: Anglès A; Bagheri H; Saivin S; Montastruc J L
Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease.
Thérapie 2002;57(4):408-10.
-
2002: Philip-Couderc P; Smih F; Pelat M; Verwaerde P; Pathak A; Buys S; Montastruc J L; Senard J M; Rouet P
[Early atrial gene regulation of obesity-related arterial hypertension]
Archives des maladies du coeur et des vaisseaux 2002;95(7-8):695-9.
-
2002: Pathak A; Verwaerde P; Galinier M; Pelat M; Couderc P Philip; Rouet P; Smih F; Buys S; Montastruc J L; Senard J M
[Study of ventricular repolarization in an experimental model of arterial hypertension associated with obesity]
Archives des maladies du coeur et des vaisseaux 2002;95(7-8):651-5.
-
2002: Pathak Atul; Boveda Serge; Defaye Pascal; Mansourati Jacques; Mallaret Michel; Thebault Laurent; Galinier Michel; Blanc Jean Jacques; Montastruc Jean Louis
Celecoxib-associated torsade de pointes.
The Annals of pharmacotherapy 2002;36(7-8):1290-1.
-
2002: Montastruc J L; Pathak A; Lapeyre-Mestre M
Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Lancet 2002;359(9324):2202; author reply 2203-4.
-
2002: Vernejoul Fabienne; Damase-Michel Christine; Montastruc Jean-Louis; Tran Marie-Antoinette
In vivo effects of fenoldopam on autonomic nervous system after inhibition or activation of ganglionic transmission.
European journal of pharmacology 2002;444(3):197-202.
-
2002: Pelat Michel; Verwaerde Patrick; Tran Marie-Antoinette; Montastruc Jean-Louis; Senard Jean-Michel
Alpha2 -adrenoceptor function in arterial hypertension associated with obesity in dogs fed a high-fat diet.
Journal of hypertension 2002;20(5):957-64.
-
2002: Montastruc Jean-Louis; Lapeyre-Mestre Maryse; Bagheri Haleh; Damase-Michel Christine
[Pharmacoepidemiology in clinical practice]
La Revue du praticien 2002;52(7):701-3.
-
2002: Brunt E R; Brooks D J; Korczyn A D; Montastruc J-L; Stocchi F;
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(4):489-502.
-
2002: Llau M E; Lapeyre-Mestre M; Plas L; Damase-Michel C; Montastruc J L
Forged medical prescriptions in a community pharmacy network in Midi-Pyrénées area: assessment of a falsification ratio.
European journal of clinical pharmacology 2002;57(12):911-2.
-
2002: Ferreira J J; Galitzky M; Thalamas C; Tiberge M; Montastruc J L; Sampaio C; Rascol O
Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers.
Neurology 2002;58(3):460-2.
-
2002: Olivier Pascale; Boulbés Olivier; Tubery Marie; Lauque Dominique; Montastruc Jean-Louis; Lapeyre-Mestre Maryse
Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.
Drug safety : an international journal of medical toxicology and drug experience 2002;25(14):1035-44.
-
2001: Simiand-Erdociain E; Lapeyre-Mestre M; Bagheri-Charabiani H; Montastruc J L
Drug consumption in a very elderly community-dwelling population.
European journal of clinical pharmacology 2001;57(9):691-2.
-
2001: Jean R; Ducasse J L; Montastruc J L; Lapeyre-Mestre M
Treatment of acute renal colic in a French emergency department: a comparison of simulated cases and real cases in acute pain assessment and management.
European journal of clinical pharmacology 2001;57(9):685-9.
-
2001: Rascol O; Ferreira J; Montastruc J L
[Abnormal diurnal somnolence, "sleep attacks" and antiparkinson drugs]
Revue neurologique 2001;157(10):1313-23.
-
2001: Sulem P; Bagheri H; Faixo Y; Montastruc J L
Atorvastatin-induced diaphragmatic muscle impairment.
The Annals of pharmacotherapy 2001;35(10):1292-3.
-
2001: Curnier D; Galinier M; Pathak A; Fourcade J; Bousquet M; Senard J M; Fauvel J M; Bounhoure J P; Montastruc J L
Rehabilitation of patients with congestive heart failure with or without beta-blockade therapy.
Journal of cardiac failure 2001;7(3):241-8.
-
2001: Pelat M; Verwaerde P; Tran M A; Berlan M; Senard J M; Montastruc J L
Changes in vascular alpha 1- and alpha 2-adrenoceptor responsiveness by selegiline treatment.
Fundamental & clinical pharmacology 2001;15(4):239-45.
-
2001: Montastruc J L; Rascol O
Modafinil and pramipexole-associated somnolence.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):783-4.
-
2001: Rascol O; Arnulf I; Peyro-Saint Paul H; Brefel-Courbon C; Vidailhet M; Thalamas C; Bonnet A M; Descombes S; Bejjani B; Fabre N; Montastruc J L; Agid Y
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):708-13.
-
2001: Olivier P; Boulbès O; Tubery M; Carles P; Montastruc J L; Lapeyre-Mestre M
[Preventability of adverse effects in a medical emergency service]
Thérapie 2001;56(3):275-8.
-
2001: Bagheri H; Lapeyre-Mestre M; Levy C; Haramburu F; Hillaire-Buys D; Blayac J P; Montastruc J L
[Inter-regional differences in dysthyroidism due to amiodarone: comparison of spontaneous notifications in Aquitaine, Midi-Pyrenees and Languedoc-Roussillon]
Thérapie 2001;56(3):301-6.
-
2001: Lemoine T; Lacroix I; Lapeyre-Mestre M; Montastruc J L; Damase-Michel C
[Follow-up of 'medications and pregnancy' at the Midi-Pyrenees Pharmacovigilance Center']
Thérapie 2001;56(3):287-93.
-
2001: Haramburu F; Riché C; Montastruc J L; Blayac J P
[Prevention of adverse effects of drugs]
Thérapie 2001;56(3):273-4.
-
2001: Ferreira J J; Thalamas C; Montastruc J L; Castro-Caldas A; Rascol O
Levodopa monotherapy can induce "sleep attacks" in Parkinson's disease patients.
Journal of neurology 2001;248(5):426-7.
-
2001: Montastruc J L; Desboeuf K; Lapeyre-Mestre M; Senard J M; Rascol O; Brefel-Courbon C
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):511-4.
-
2001: Montastruc J L; Brefel-Courbon C; Senard J M; Bagheri H; Ferreira J; Rascol O; Lapeyre-Mestre M
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study.
Clinical neuropharmacology 2001;24(3):181-3.
-
2001: Descombes S; Brefel-Courbon C; Thalamas C; Albucher J F; Rascol O; Montastruc J L; Senard J M
Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study.
Headache 2001;41(2):178-82.
-
2001: Bareille M P; Montastruc J L; Lapeyre-Mestre M
[Liver damage and nonsteroidal anti-inflammatory drugs: case non-case study in the French Pharmacovigilance Database]
Thérapie 2001;56(1):51-5.
-
2001: Pathak A; Tran M A; Montastruc J L
[Atropine. Principles and rules of utilization]
La Revue du praticien 2001;51(1):59-63.
-
2001: Rascol O; Ferreira J J; Thalamas C; Galitsky M; Montastruc J L
Dopamine agonists. Their role in the management of Parkinson's disease.
Advances in neurology 2001;86():301-9.
-
2001: Senard J M; Brefel-Courbon C; Rascol O; Montastruc J L
Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.
Drugs & aging 2001;18(7):495-505.
-
2001: Rascol O; Fabre N; Brefel-Courbon C; Montastruc J L
The pharmacologic treatment of gait ignition failure.
Advances in neurology 2001;87():255-64.
-
2000: Amouyal-Barkate K; Bagheri-Charabiani H; Montastruc J L; Moulias S; Vellas B
Abnormal movements with donepezil in Alzheimer disease.
The Annals of pharmacotherapy 2000;34(11):1347.
-
2000: Lacroix I; Damase-Michel C; Lapeyre-Mestre M; Montastruc J L
Prescription of drugs during pregnancy in France.
Lancet 2000;356(9243):1735-6.
-
2000: Bagheri H; Michel F; Lapeyre-Mestre M; Lagier E; Cambus J P; Valdiguié P; Montastruc J L
Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals.
British journal of clinical pharmacology 2000;50(5):479-84.
-
2000: Brefel-Courbon C; Thalamas C; Rascol O; Montastruc J L; Senard J M
Lack of autonomic nervous dysfunction in progressive supranuclear palsy, a study of blood pressure variability.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2000;10(5):309-12.
-
2000: Couffignal A L; Lapeyre-Mestre M; Bonhomme C; Bugat R; Montastruc J L
[Adverse effects of anticancer drugs: apropos of a pharmacovigilance study at a specialized oncology institution]
Thérapie 2000;55(5):635-41.
-
2000: Desboeuf K; Senard J M; Pavy-Le-Traon A; Brefel C; Clanet M; Géraud G; Montastruc J L
[Midodrine (Gutron) prescription practice at a University Hospital Center]
Thérapie 2000;55(5):613-7.
-
2000: Montastruc J L; Chaumerliac C; Desboeuf K; Manika M; Bagheri H; Rascol O; Lapeyre-Mestre M
Adverse drug reactions to selegiline: a review of the French pharmacovigilance database.
Clinical neuropharmacology 2000;23(5):271-5.
-
2000: Lazartigues E; Brefel-Courbon C; Bagheri H; Costes S; Gharib C; Tran M A; Senard J M; Montastruc J L
Fluoxetine-induced pressor response in freely moving rats: a role for vasopressin and sympathetic tone.
Fundamental & clinical pharmacology 2000;14(5):443-51.
-
2000: Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc J L
[Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region]
Archives des maladies du coeur et des vaisseaux 2000;93(8):925-9.
-
2000: Brefel-Courbon C; Simonetta-Moreau M; Moré C; Rascol O; Clanet M; Montastruc J L; Lapeyre-Mestre M
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis.
Clinical neuropharmacology 2000;23(4):203-7.
-
2000: Thalamas C; Galitzky J; Sénard J M; Lafontan M; Montastruc J L; Berlan M; Barbe P
Glucose-induced sympathetic activity and energy expenditure during acute alpha2-adrenergic antagonism in obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(6):695-700.
-
2000: Rémy N; Lapeyre-Mestre M; Bareille M P; Bagheri H; Montastruc J L
[Drug interactions: a prospective pilot study in primary health care]
Thérapie 2000;55(3):395-8.
-
2000: Pelagatti V; Bagheri H; Fernandez P; Railhac N; Bregeon C; Railhac J J; Montastruc J L
[Adverse effects of contrast media: results of a 6 months study]
Thérapie 2000;55(3):391-4.
-
2000: Bagheri H; Lhiaubet V; Montastruc J L; Chouini-Lalanne N
Photosensitivity to ketoprofen: mechanisms and pharmacoepidemiological data.
Drug safety : an international journal of medical toxicology and drug experience 2000;22(5):339-49.
-
2000: Ferreira J J; Galitzky M; Montastruc J L; Rascol O
Sleep attacks and Parkinson's disease treatment.
Lancet 2000;355(9212):1333-4.
-
2000: Montastruc J L
Treatment of Parkinson's disease should begin with a dopamine agonist.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):361-2.
-
2000: Damase-Michel C; Lapeyre-Mestre M; Moly C; Fournié A; Montastruc J L
[Drug use during pregnancy: survey in 250 women consulting at a university hospital center]
Journal de gynécologie, obstétrique et biologie de la reproduction 2000;29(1):77-85.
-
2000: Sabatini U; Boulanouar K; Fabre N; Martin F; Carel C; Colonnese C; Bozzao L; Berry I; Montastruc J L; Chollet F; Rascol O
Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study.
Brain : a journal of neurology 2000;123 ( Pt 2)():394-403.
-
2000: Curnier D; Galinier M; Fourcade J; Bousquet M; Bovéda S; Delay M; Sénard J M; Fauvel J M; Bounhoure J P; Montastruc J L
[Utilization of heart rate at the ventilatory threshold for the prescription of intensity of exercise training in cardiac failure]
Archives des maladies du coeur et des vaisseaux 2000;93(1):71-8.
-
2000: Bagheri H; Frelezeau F; Montastruc J L
[Adverse effects of locally applied drugs]
Thérapie 2000;55(1):211-9.
-
2000: Rascol O; Montastruc J L
[Role of dopaminergic agonists]
Revue neurologique 2000;156 Suppl 2 Pt 2():98-104.
-
1999: Montastruc J L; Dutkiewicz R; Llau-Bousquet-Melou M E; Lapeyre-Mestre M
[Undesirable effects of spa treatments: apropos of a systematic, prospective spa surveillance study at Bagnères-de-Bigorre]
Thérapie 1999;54(6):669-73.
-
1999: Pelat M; Verwaerde P; Merial C; Galitzky J; Berlan M; Montastruc J L; Senard J M
Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension.
Hypertension 1999;34(5):1066-72.
-
1999: Montastruc J L; Rascol O; Senard J M
Treatment of Parkinson's disease should begin with a dopamine agonist.
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):725-30.
-
1999: Pelat M; Lazartigues E; Tran M A; Gharib C; Montastruc J L; Montastruc P; Rascol O
Characterization of the central muscarinic cholinoceptors involved in the cholinergic pressor response in anesthetized dogs.
European journal of pharmacology 1999;379(2-3):117-24.
-
1999: Desboeuf K; Lapeyre-Mestre M; Montastruc J L
[Calcium inhibiting drugs and the risk of gastrointestinal hemorrhage. A pharmaco-epidemiologic case-non-case study]
Archives des maladies du coeur et des vaisseaux 1999;92(8):1095-9.
-
1999: Lazartigues E; Costes S; Brefel-Courbon C; Gharib C; Tran M A; Senard J M; Montastruc J L
[Reduction of the pressor effect of fluoxetine after V1A-vasopressin receptor blockade in the conscious rats]
Archives des maladies du coeur et des vaisseaux 1999;92(8):985-9.
-
1999: Verwaerde P; Sénard J M; Galinier M; Rougé P; Massabuau P; Galitzky J; Berlan M; Lafontan M; Montastruc J L
Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs.
Journal of hypertension 1999;17(8):1135-43.
-
1999: Lazartigues E; Brefel-Courbon C; Tran M A; Montastruc J L; Rascol O
Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanisms.
British journal of pharmacology 1999;127(7):1657-65.
-
1999: Filloux M C; Maréchal K; Bagheri H; Morales J; Nouvel A; Laurencin G; Montastruc J L
Phenothiazine-induced acute colitis: a positive rechallenge case report.
Clinical neuropharmacology 1999;22(4):244-5.
-
1999: Bagheri H; Damase-Michel C; Lapeyre-Mestre M; Cismondo S; O'Connell D; Senard J M; Rascol O; Montastruc J L
A study of salivary secretion in Parkinson's disease.
Clinical neuropharmacology 1999;22(4):213-5.
-
1999: Senard J M; Brefel C; Carel C; Tran M A; Montastruc J L
Water drinking and the heart.
Lancet 1999;353(9168):1971-2.
-
1999: Lapeyre-Mestre M; Chastan E; Louis A; Montastruc J L
Drug consumption in workers in France: a comparative study at a 10-year interval (1996 versus 1986).
Journal of clinical epidemiology 1999;52(5):471-8.
-
1999: Montastruc J L; Bagheri H; Lapeyre-Mestre M; Senard J M
[Pharmacological vigilance and pharmacological epidemiology: principles, definition, methods and current trends in neurology]
Revue neurologique 1999;155(4):312-24.
-
1999: Bagheri H; Bernhard N B; Montastruc J L
Potentiation of the acenocoumarol anticoagulant effect by acetaminophen.
The Annals of pharmacotherapy 1999;33(4):506.
-
1999: Montastruc J L; Ziegler M; Rascol O; Malbezin M
A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):336-41.
-
1999: Bagheri H; Cismondo S; Montastruc J L
[Drug-induced hiccup: a review of the France pharmacologic vigilance database]
Thérapie 1999;54(1):35-9.
-
1999: Andreu N; Chalé J J; Senard J M; Thalamas C; Montastruc J L; Rascol O
L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers.
Clinical neuropharmacology 1999;22(1):15-23.
-
1999: Rascol O; Brefel-Courbon C; Descombes S; Montastruc J L
Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
Advances in neurology 1999;80():485-90.
-
1999: Montastruc J L; Verwaerde P; Pelat M; Galitzky J; Langin D; Lafontan M; Berlan M
Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect.
Fundamental & clinical pharmacology 1999;13(2):180-6.
-
1998: Lazartigues E; Freslon J L; Tellioglu T; Brefel-Courbon C; Pelat M; Tran M A; Montastruc J L; Rascol O
Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat.
European journal of pharmacology 1998;361(1):61-71.
-
1998: Damase-Michel C; Tran M A; Montastruc J L; Montastruc P
Effect of losartan on afferent nerve stimulation.
European journal of pharmacology 1998;355(2-3):125-32.
-
1998: Cabrol P; Galinier M; Fourcade J; Verwaerde P; Massabuau P; Tran M A; Montastruc J L; Bounhoure J P; Fauvel J M; Sénard J M
[Functional decoupling of left ventricular beta-adrenoceptor in a canine model of obesity-hypertension]
Archives des maladies du coeur et des vaisseaux 1998;91(8):1021-4.
-
1998: Pelat M; Verwaerde P; Lazartiques E; Cabrol P; Galitzky J; Berlan M; Montastruc J L; Senard J M
[Twenty-four hour time and frequency domain variability of systolic blood pressure and heart rate in an experimental model of arterial hypertension plus obesity]
Archives des maladies du coeur et des vaisseaux 1998;91(8):999-1002.
-
1998: Desboeuf K; Lapeyre-Mestre M; Montastruc J L
Risk of gastrointestinal haemorrhage with calcium antagonists.
British journal of clinical pharmacology 1998;46(1):88-9.
-
1998: Fabre N; Brefel C; Sabatini U; Celsis P; Montastruc J L; Chollet F; Rascol O
Normal frontal perfusion in patients with frozen gait.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):677-83.
-
1998: Rascol O; Sieradzan K; Peyro-Saint-Paul H; Thalamas C; Brefel-Courbon C; Senard J M; Ladure P; Montastruc J L; Lees A
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):673-6.
-
1998: Allal C; Lazartigues E; Tran M A; Brefel-Courbon C; Gharib C; Montastruc J L; Rascol O
Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin release.
European journal of pharmacology 1998;348(2-3):191-8.
-
1998: Galitzky J; Langin D; Montastruc J L; Lafontan M; Berlan M
On the presence of a putative fourth beta-adrenoceptor in human adipose tissue.
Trends in pharmacological sciences 1998;19(5):164-6.
-
1998: Brefel C; Thalamas C; Rayet S; Lopez-Gil A; Fitzpatrick K; Bullman S; Citerone D R; Taylor A C; Montastruc J L; Rascol O
Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.
British journal of clinical pharmacology 1998;45(4):412-5.
-
1998: Rascol O; Sabatini U; Brefel C; Fabre N; Rai S; Senard J M; Celsis P; Viallard G; Montastruc J L; Chollet F
Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.
Brain : a journal of neurology 1998;121 ( Pt 3)():527-33.
-
1998: Montastruc J L; Tran M A
[Atropine]
La Revue du praticien 1998;48(1):85-7.
-
1998: Bagheri H; Broué P; Lacroix I; Larrey D; Olives J P; Vaysse P; Ghisolfi J; Montastruc J L
Fulminant hepatic failure after herbal medicine ingestion in children.
Thérapie 1998;53(1):82-3.
-
1998: Senard J M; Montastruc J L
[Pharmacologic approach to autonomic failure]
Thérapie 1998;53(1):35-41.
-
1998: Lapeyre-Mestre M; Desboeuf K; Aptel I; Chale J J; Montastruc J L
A comparative survey of antidepressant drug prescribing habits of general practitioners and psychiatrists.
Clinical drug investigation 1998;16(1):53-61.
-
1998: Lazartigues E; Tran M A; Brefel-Courbon C; Montastruc J L; Rascol O
Endogenous central cholinergic systems and baroreflex modulation in the conscious dog.
Fundamental & clinical pharmacology 1998;12(6):643-5.
-
1998: Montastruc J L; Pelat M; Verwaerde P; Brefel-Courbon C; Tran M A; Blin O; Rascol O; Senard J M
Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot study.
Fundamental & clinical pharmacology 1998;12(4):398-402.
-
1998: Rinne U K; Bracco F; Chouza C; Dupont E; Gershanik O; Marti Masso J F; Montastruc J L; Marsden C D
Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study Group.
Drugs 1998;55 Suppl 1():23-30.
-
1997: Massip P; Marchou B; Bonnet E; Cuzin L; Montastruc J L
Lipodystrophia with protease inhibitors in HIV patients.
Thérapie 1997;52(6):615.
-
1997: Senard J M; Raï S; Lapeyre-Mestre M; Brefel C; Rascol O; Rascol A; Montastruc J L
Prevalence of orthostatic hypotension in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1997;63(5):584-9.
-
1997: Galitzky J; Langin D; Verwaerde P; Montastruc J L; Lafontan M; Berlan M
Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
British journal of pharmacology 1997;122(6):1244-50.
-
1997: Agid Y; Destée A; Durif F; Montastruc J L; Pollak P
Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group.
Lancet 1997;350(9079):712-3.
-
1997: Verwaerde P; Galinier M; Fourcade J; Massabuau P; Galitzky J; Senard J M; Tran M A; Berlan M; Montastruc J L
[Autonomic nervous system abnormalities in the initial phase of insulin resistance syndrome. Value of the study of variability of cardiac rate and blood pressure on a model of nutritional obesity]
Archives des maladies du coeur et des vaisseaux 1997;90(8):1151-4.
-
1997: Massabuau P; Verwaerde P; Galinier M; Fourcade J; Rougé P; Galitzky J; Senard J M; Berlan M; Bounhoure J P; Montastruc J L
[Left ventricular repercussion of obesity-induced arterial hypertension in the dog]
Archives des maladies du coeur et des vaisseaux 1997;90(8):1033-5.
-
1997: Bénézet S; Chatelut E; Bagheri H; Rigal-Huguet F; Nguyen L; Pourrat J; Robert A; Montastruc J L; Canal P
[Inefficacy of exchange-transfusion in case of a methotrexate poisoning]
Bulletin du cancer 1997;84(8):788-90.
-
1997: Montastruc J L; Rascol O; Senard J M
Glutamate antagonists and Parkinson's disease: a review of clinical data.
Neuroscience and biobehavioral reviews 1997;21(4):477-80.
-
1997: Montastruc J L; Llau-Bousquet M E; Senard J M; Rascol O
[Movement disorders of drug origin]
La Revue du praticien 1997;47(10):1109-16.
-
1997: Andreu N; Damase-Michel C; Senard J M; Rascol O; Montastruc J L
A dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activity.
Movement disorders : official journal of the Movement Disorder Society 1997;12(3):293-6.
-
1997: Montastruc J L; Sénard J M; Lapeyre-Mestre M
[Apropos of recent antidepressant drugs: some pharmacological comments]
Thérapie 1997;52(2):143-9.
-
1997: Montastruc J L; Bagheri H; Geraud T; Lapeyre-Mestre M
[Pharmacovigilance of self-medication]
Thérapie 1997;52(2):105-10.
-
1997: Rinne U K; Bracco F; Chouza C; Dupont E; Gershanik O; Marti Masso J F; Montastruc J L; Marsden C D; Dubini A; Orlando N; Grimaldi R
Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group.
Neurology 1997;48(2):363-8.
-
1997: Galinier M; Rougé P; Fourcade J; Senard J M; Albenque J P; Balanescu S; Doazan J P; Montastruc J L; Bounhoure J P; Montastruc P
Lack of haemodynamic effects of nitric oxide on post-capillary pulmonary hypertension induced by acute sino-aortic denervation.
British journal of pharmacology 1997;120(1):7-12.
-
1997: Rascol O; Sabatini U; Fabre N; Brefel C; Loubinoux I; Celsis P; Senard J M; Montastruc J L; Chollet F
The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients.
Brain : a journal of neurology 1997;120 ( Pt 1)():103-10.
-
1997: Verwaerde P; Tran M A; Montastruc J L; Senard J M; Portolan G
Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension.
Fundamental & clinical pharmacology 1997;11(6):567-75.
-
1997: Lapeyre-Mestre M; Gary J; Machelard-Roumagnac M; Bonhomme C; Bugat R; Montastruc J L
Incidence and cost of adverse drug reactions in a French cancer institute.
European journal of clinical pharmacology 1997;53(1):19-22.
-
1997: Bagheri H; Schmitt L; Berlan M; Montastruc J L
A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs.
European journal of clinical pharmacology 1997;52(5):339-42.
-
1997: Bordet R; Verwaerde P; Tran M A; Marques M A; Montastruc J L; Senard J M
Effects of octreotide on experimental neurogenic orthostatic hypotension in anaesthetized dogs.
Fundamental & clinical pharmacology 1997;11(3):237-44.
-
1997: Lapeyre-Mestre M; Damase-Michel C; Adams P; Michaud P; Montastruc J L
Falsified or forged medical prescriptions as an indicator of pharmacodependence: a pilot study. Community pharmacists of the Midi-Pyrénées.
European journal of clinical pharmacology 1997;52(1):37-9.
-
1996: Llau M E; Durrieu G; Tran M A; Senard J M; Rascol O; Montastruc J L
A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
Clinical neuropharmacology 1996;19(5):420-7.
-
1996: Leclerc C; Debas A; Bagheri H; Montastruc J L
[Apropos of a prospective systematic survey of pharmacovigilance in chemist's shops]
Thérapie 1996;51(5):563-4.
-
1996: Riotte C; Duchesne P; Lapeyre-Mestre M; Pezous A M; Bagheri H; Damase-Michel C; Schmitt L; Montastruc J L
[Pharmacoepidemiological study of methadone in a center of addiction management: adverse effects and combined drug consumption]
Thérapie 1996;51(5):557-9.
-
1996: Bagheri H; Galian M E; Bastie D; Couffignal A L; Tafani J A; Fourcade C; Morena I; Guiraud R; Montastruc J L
[Prospective survey on adverse effects of radiopharmaceuticals]
Thérapie 1996;51(5):550-3.
-
1996: Montastruc J L; Rascol O; Senard J M
New directions in the drug treatment of Parkinson's disease.
Drugs & aging 1996;9(3):169-84.
-
1996: Verwaerde P; Bordet R; Portolan G; Tran M A; Marques M A; Montastruc J L; Sénard J M
[Effects of octreotide on experimental orthostatic neurogenic hypotension]
Archives des maladies du coeur et des vaisseaux 1996;89(8):1097-1101.
-
1996: Verwaerde P; Galinier M; Rougé P; Massabuau P; Galitzky J; Sénard J M; Berlan M; Montastruc J L
[Experimental hypertension induced by hypercaloric diet]
Archives des maladies du coeur et des vaisseaux 1996;89(8):1019-23.
-
1996: Advenier C; Avouac B; Bechtel P; Boissel J P; Calvo F; Jardin A; Lagier G; Lechat P; Montastruc J L; Puech A; Royer R J; Thuillez C; Tillement J P
First Congress of the European Association for Clinical Pharmacology and Therapeutics.
Thérapie 1996;51(4):341-7.
-
1996: Montastruc J L; Rascol O; Senard J M
The discovery of vasomotor nerves.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1996;6(3):183-7.
-
1996: Rascol O; Lees A J; Senard J M; Pirtosek Z; Montastruc J L; Fuell D
Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.
Clinical neuropharmacology 1996;19(3):234-45.
-
1996: Verwaerde P; Senard J M; Mazerolles M; Tran M A; Damase-Michel C; Montastruc J L; Montastruc P
Spectral analysis of blood pressure and heart rate, catecholamine and neuropeptide Y plasma levels in a new model of neurogenic orthostatic hypotension in dog.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1996;6(2):75-82.
-
1996: Montastruc J L; Llau M E; Senard J M; Tran M A; Rascol O; Montastruc P
A study of tolerance to apomorphine.
British journal of pharmacology 1996;117(5):781-6.
-
1996: Lemozit J P; De La Rhodiere G P; Lapeyre-Mestre M; Bagheri H; Montastruc J L
A comparative study of adverse drug reactions reported through hospital and private medicine.
British journal of clinical pharmacology 1996;41(2):166-8.
-
1996: Dubois B; Montastruc J L
[Levodopa+selegiline combination and increase of risk of mortality in the treatment of Parkinson disease]
Revue neurologique 1996;152(2):103-5.
-
1996: Montastruc M; Montastruc J L
[Iatrogenic agranulocytosis. Etiology, diagnosis, treatment]
La Revue du praticien 1996;46(2):219-21.
-
1996: Montastruc J L; Rascol O; Senard J M
Neuroprotection in Parkinson's disease.
Lancet 1996;347(8995):196.
-
1996: Mazerolles M; Senard J M; Verwaerde P; Tran M A; Montastruc J L; Virenque C; Montastruc P
Effects of pentobarbital and etomidate on plasma catecholamine levels and spectral analysis of blood pressure and heart rate in dogs.
Fundamental & clinical pharmacology 1996;10(3):298-303.
-
1996: Senard J M; Montastruc J L
Which drug for which orthostatic hypotension?
Fundamental & clinical pharmacology 1996;10(3):225-33.
-
1996: Rascol O; Lees A J; Senard J M; Pirtosek Z; Brefel C; Montastruc J L; Fuell D
A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.
Advances in neurology 1996;69():531-4.
-
1996: Montastruc J L; Senard J M; Rascol O; Rascol A
Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences.
Advances in neurology 1996;69():377-81.
-
1995: Rascol O; Hain T C; Brefel C; Benazet M; Clanet M; Montastruc J L
Antivertigo medications and drug-induced vertigo. A pharmacological review.
Drugs 1995;50(5):777-91.
-
1995: Brefel C; Lazartigues E; Tran M A; Gauquelin G; Geelen G; Gharib C; Montastruc J L; Montastruc P; Rascol O
Central cardiovascular effects of acetylcholine in the conscious dog.
British journal of pharmacology 1995;116(4):2175-82.
-
1995: Lemozit J P; Vabre F; Lapeyre-Mestre M; Damase-Michel C; Montastruc J L
[Could you give me this drug without prescription?]
Thérapie 1995;50(5):464-6.
-
1995: Pouget-Zago P; Lapeyre-Mestre M; Bagheri H; Montastruc J L
[Pharmacovigilance seen by a selected group of general practitioners and of residents in the Midi-Pyrénées region]
Thérapie 1995;50(5):459-62.
-
1995: Sacilotto K; Bagheri H; Lapeyre-Mestre M; Montastruc J L; Montastruc P
[Adverse drug effect notifications by nurses and comparison with cases reported by physicians]
Thérapie 1995;50(5):455-8.
-
1995: Llau M E; Senard J M; Rascol O; Montastruc J L
[Movement disorders induced by drugs: experience at a pharmaco-vigilance center over five years]
Thérapie 1995;50(5):425-7.
-
1995: Vigreux P; Lemozit J P; Delay M; Bernadet P; Montastruc J L
Antiarrhythmic drug-induced side effects: a prospective survey of 300 patients.
Thérapie 1995;50(5):413-8.
-
1995: Damase-Michel C; Bompart G; Durrieu G; Montastruc J L; Montastruc P; Girolami J P
Relationships between kallikrein secretion, kallikrein excretion and beta-adrenoceptors in kidney cortical slices from neurogenic hypertensive dogs.
British journal of pharmacology 1995;116(1):1704-10.
-
1995: Galinier M; Rougé P; Albenque J P; Assoun B; Massabuau P; Fauvel J M; Bounhoure J P; Montastruc J L; Montastruc P
[Absence of the effect of nitric oxide on pulmonary and systemic hypertension induced by sino-aortic denervation]
Archives des maladies du coeur et des vaisseaux 1995;88(8):1209-12.
-
1995: Sanchez P; Damase-Michel C; Tran M A; Montastruc J L
Involvement of renal dopaminergic system in experimental neurogenic arterial hypertension.
Hypertension research : official journal of the Japanese Society of Hypertension 1995;18 Suppl 1():S187-90.
-
1995: Sénard J M; Verwaerde P; Rascol O; Montastruc J L
Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsonians.
Hypertension research : official journal of the Japanese Society of Hypertension 1995;18 Suppl 1():S175-7.
-
1995: Damase-Michel C; Montastruc J L; Tran M A
Effects of dopaminergic drugs on the sympathoadrenal system.
Hypertension research : official journal of the Japanese Society of Hypertension 1995;18 Suppl 1():S119-24.
-
1995: Montastruc J L; Fabre N; Blin O; Senard J M; Rascol O; Rascol A
Does fluoxetine aggravate Parkinson's disease? A pilot prospective study.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):355-7.
-
1995: Rascol O; Sabatini U; Fabre N; Senard J M; Simonetta-Moreau M; Montastruc J L; Clanet M; Rascol A
Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):163-70.
-
1995: Llau M E; Viraben R; Montastruc J L
[Drug-induced alopecia: review of the literature]
Thérapie 1995;50(2):145-50.
-
1995: Bonnet M; Angibaud G; Cantagrel A; Montastruc J L; Clanet M
[Myasthenia induced by tiopronin in the treatment of rheumatoid arthritis]
Revue neurologique 1995;151(1):67-8.
-
1995: Chabrol H; Montastruc J L
Metoclopramide-induced panic attacks.
European psychiatry : the journal of the Association of European Psychiatrists 1995;10(3):163.
-
1995: Montastruc J L; Rascol O; Senard J M; Houin G; Rascol A
Sublingual apomorphine: a new pharmacological approach in Parkinson's disease?
Journal of neural transmission. Supplementum 1995;45():157-61.
-
1995: Allain P; Le Bouil A; Cordillet E; Le Quay L; Bagheri H; Montastruc J L
Sulfate and cysteine levels in the plasma of patients with Parkinson's disease.
Neurotoxicology 1995;16(3):527-9.
-
1995: Bagheri H; Chale J J; Guyen L N; Tran M A; Berlan M; Montastruc J L
Evidence for activation of both adrenergic and cholinergic nervous pathways by yohimbine, an alpha 2-adrenoceptor antagonist.
Fundamental & clinical pharmacology 1995;9(3):248-54.
-
1995: Berlan M; Galitzky J; Montastruc J L
Beta 3-adrenoceptors in the cardiovascular system.
Fundamental & clinical pharmacology 1995;9(3):234-9.
-
1994: Montastruc J L; Lapeyre-Mestre M; Llau M E; Senard J M; Rascol O; Montastruc P
Naloxone does not prevent apomorphine-induced emesis or hypotension in dogs.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1994;4(6):303-5.
-
1994: Pourrat J; Montastruc J L; Lacombe J L; Cisterne J M; Rascol O; Dumazer P
[Nephropathy associated with Chinese herbal drugs. 2 cases]
Presse médicale (Paris, France : 1983) 1994;23(36):1669.
-
1994: Llau M E; Nguyen L; Senard J M; Rascol O; Montastruc J L
[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]
Revue neurologique 1994;150(11):757-62.
-
1994: Montastruc J L; Rascol O; Senard J M; Rascol A
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
Journal of neurology, neurosurgery, and psychiatry 1994;57(9):1034-8.
-
1994: Veronese L; Damase-Michel C; Montastruc J L
[Adverse drug effect in pregnancy: evaluation at the Midi-Pyrénées center]
Thérapie 1994;49(5):473-5.
-
1994: Llau M E; Nguyen L; Senard J M; Rascol O; Montastruc J L
[Drug-induced Parkinson syndrome: 10 years of drug vigilance]
Thérapie 1994;49(5):459-60.
-
1994: Graille V; Lapeyre-Mestre M; Montastruc J L
[Drug vigilance: opinion survey among residents of a university hospital]
Thérapie 1994;49(5):451-4.
-
1994: Graille V; Lapeyre-Mestre M; Montastruc J L
[Amiodarone-induced pleuropneumopathies: experience 1983-1993 in a drug vigilance Regional Center]
Thérapie 1994;49(5):421-4.
-
1994: Chamontin B; Amar J; Bégasse F; Tran M A; Senard J M; Montastruc J L; Salvador M
[Ambulatory measurement of blood pressure and plasma catecholamines in the study of orthostatic hypotension]
Archives des maladies du coeur et des vaisseaux 1994;87(8):1087-91.
-
1994: Galinier M; Senard J M; Srour A; Ligou V; Valet P; Glock Y; Massabuau P; Roux D; Montastruc J L; Bounhoure J P
[Changes in myocardial beta adrenergic receptors in left ventricular hypertrophy caused by barometric and volumetric overloads]
Archives des maladies du coeur et des vaisseaux 1994;87(8):1015-8.
-
1994: Rascol O; Fabre N; Blin O; Poulik J; Sabatini U; Senard J M; Ané M; Montastruc J L; Rascol A
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1994;9(4):437-40.
-
1994: Damase-Michel C; Giraud P; Portolan G; Montastruc J L; Montastruc P; Tran M A
Effects of insulin on the release of neuropeptide Y, [Met5]enkephalin and catecholamines from dog adrenal medulla.
European journal of pharmacology 1994;258(3):277-9.
-
1994: Rascol O; Sabatini U; Chollet F; Fabre N; Senard J M; Montastruc J L; Celsis P; Marc-Vergnes J P; Rascol A
Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa.
Journal of neurology, neurosurgery, and psychiatry 1994;57(5):567-71.
-
1994: Montastruc J L; Fabre N; Rascol O; Senard J M; Blin O
N-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphan.
Movement disorders : official journal of the Movement Disorder Society 1994;9(2):242-3.
-
1994: Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc J L
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
The Journal of pharmacology and experimental therapeutics 1994;268(3):1444-51.
-
1994: Montastruc J L; Senard J M; Verwaerde P; Montastruc P
[Physiological mechanisms of cardiovascular adaptation to orthostatism. Role of the sympathetic nervous system and pharmacological implications]
Thérapie 1994;49(2):81-7.
-
1994: Rascol O; Montastruc J L
[Drug therapy of vertigo]
La Revue du praticien 1994;44(3):354-60.
-
1994: Bagheri H; Berlan M; Senard J M; Rascol O; Montastruc J L
Lacrimation in Parkinson's disease.
Clinical neuropharmacology 1994;17(1):89-91.
-
1994: Bagheri H; Picault P; Schmitt L; Houin G; Berlan M; Montastruc J L
Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.
British journal of clinical pharmacology 1994;37(1):93-6.
-
1994: Pascali P; Sorbette F; Senard J M; Fabre N; Rascol O; Montastruc J L
[Apropos of secondary effects of hydroxyzine]
Thérapie 1994;49(1):56.
-
1994: Galinier M; Sénard J M; Valet P; Arias A; Daviaud D; Glock Y; Bounhoure J P; Montastruc J L
Cardiac beta-adrenoceptors and adenylyl cyclase activity in human left ventricular hypertrophy due to pressure overload.
Fundamental & clinical pharmacology 1994;8(1):90-9.
-
1994: Fournié A; Graille V; Montastruc J L
[Bromocriptine, lactation inhibition and drug monitoring]
Journal de gynécologie, obstétrique et biologie de la reproduction 1994;23(2):129-30.
-
1994: Montastruc J L; Llau M E; Rascol O; Senard J M
Drug-induced parkinsonism: a review.
Fundamental & clinical pharmacology 1994;8(4):293-306.
-
1993: Galinier M; Sénard J M; Valet P; Glock Y; Fournial G; Massabuau P; Puel J; Montastruc J L; Bounhoure J P
Changes in beta-adrenergic receptivity during human left ventricular hypertrophy due to pressure overload.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S184-5.
-
1993: Senard J M; Montastruc J L
Adrenoceptor regulation in orthostatic hypotension during autonomic failure.
Trends in pharmacological sciences 1993;14(10):349-51.
-
1993: Damase-Michel C; Tavernier G; Giraud P; Montastruc J L; Montastruc P; Tran M A
Effects of clonidine, dihydralazine and splanchnic nerve stimulation on the release of neuropeptide Y, MET-enkephalin and catecholamines from dog adrenal medulla.
Naunyn-Schmiedeberg's archives of pharmacology 1993;348(4):379-84.
-
1993: Jacques J P; Llau M E; Mercier J F; Vigreux P; Montastruc J L
[Drug-induced esophageal ulcer. Apropos of a new case]
Thérapie 1993;48(5):516.
-
1993: Montastruc J L; Galitzky J; Berlan M; Montastruc P
[Mechanism of receptor regulation during repeated administration of drugs]
Thérapie 1993;48(5):421-6.
-
1993: Montastruc J L; Rascol O; Senard J M
Current status of dopamine agonists in Parkinson's disease management.
Drugs 1993;46(3):384-93.
-
1993: Tran M A; Damase-Michel C; Tavernier G; Giraud P; Montastruc J L; Montastruc P
[Co-release of neuropeptides and catecholamines by adrenal medulla]
Archives des maladies du coeur et des vaisseaux 1993;86(8):1253-6.
-
1993: Galinier M; Senard J M; Valet P; Glock Y; Fournial G; Cerene A; Puel J; Montastruc J L; Bounhoure J P
[Beta-adrenergic receptivity and left ventricular hypertrophy caused by pressure overload in man]
Archives des maladies du coeur et des vaisseaux 1993;86(8):1099-103.
-
1993: Fabre N; Montastruc J L; Rascol O
Alopecia: an adverse effect of bromocriptine.
Clinical neuropharmacology 1993;16(3):266-8.
-
1993: Orfila C; Damase-Michel C; Lepert J C; Montastruc J L; Suc J M; Montastruc P; Girolami J P
Renal morphological changes after sinoaortic denervation in dogs.
Hypertension 1993;21(6 Pt 1):758-66.
-
1993: Petit de la Rhodière G; Sorbette F; Montastruc J L; Montastruc P
[Fatal adverse effects. Experience of the Midi-Pyrénées Pharmacovigilance Center]
Thérapie 1993;48(2):160-1.
-
1993: Jacquet A; Sorbette F; Montastruc J L
[Evaluation of ten years of pharmacovigilance of antihypertensive drugs in the Toulouse University Regional Hospital Center (1981-1990)]
Thérapie 1993;48(2):141-4.
-
1993: Senard J M; Rascol O; Durrieu G; Tran M A; Berlan M; Rascol A; Montastruc J L
Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy.
Clinical neuropharmacology 1993;16(1):70-6.
-
1993: Montastruc J L; Chamontin B; Senard J M; Tran M A; Rascol O; Llau M E; Rascol A
Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline.
Lancet 1993;341(8844):555.
-
1993: Montastruc P; Montastruc J L; Dubreuil J; Galiano A
Effect of oxodipine, a novel dihydropyridine calcium channel blocker, in neurogenic hypertensive dogs.
Archives internationales de pharmacodynamie et de thérapie 1993;321():57-62.
-
1993: Damase-Michel C; Tran M A; Llau M E; Chollet F; Senard J M; Guiraud-Chaumeil B; Montastruc J L; Montastruc P
The effect of yohimbine on sympathetic responsiveness in essential hypertension.
European journal of clinical pharmacology 1993;44(2):199-201.
-
1993: Rascol O J; Sabatini U; Chollet F; Montastruc J L; Marc-Vergnes J P; Rascol A
Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.
Advances in neurology 1993;60():419-21.
-
1993: Rascol O J; Clanet M; Senard J M; Montastruc J L; Rascol A
Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophy.
Advances in neurology 1993;60():395-7.
-
1993: Tavernier G; Sénard J M; Montastruc J L; Montastruc P
A study of alpha 1- and alpha 2-adrenoceptor responsiveness in diabetic insipidus dogs.
Fundamental & clinical pharmacology 1993;7(6):275-80.
-
1993: Senard J M; Rascol O; Rascol A; Montastruc J L
Lack of yohimbine effect on ambulatory blood pressure recording: a double-blind cross-over trial in parkinsonians with orthostatic hypotension.
Fundamental & clinical pharmacology 1993;7(8):465-70.
-
1993: Alran C; Damase-Michel C; Celotto N; Durand M C; Montastruc J L
Consumption of benzodiazepines in a French university hospital between 1980 and 1991.
Fundamental & clinical pharmacology 1993;7(6):319-23.
-
1993: Senard J M; Rascol O; Chamontin B; Rascol A; Montastruc J L
[Ambulatory monitoring of blood pressure in orthostatic hypotension of Parkinson disease]
Revue neurologique 1993;149(10):541-6.
-
1992: Bagheri H; Schmitt L; Berlan M; Montastruc J L
Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants.
British journal of clinical pharmacology 1992;34(6):555-8.
-
1992: Tavernier G; Galitzky J; Bousquet-Melou A; Montastruc J L; Berlan M
The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms.
The Journal of pharmacology and experimental therapeutics 1992;263(3):1083-90.
-
1992: Montastruc J L; Rascol O; Montastruc P
Naloxone or haloperidol but not yohimbine reverse apomorphine-induced respiratory depression.
Clinical neuropharmacology 1992;15(5):404-7.
-
1992: Sorbette F; Conte S; Montastruc J L
[Role of adverse effects of immuno-allergic nature at a Regional Pharmacovigilance Center]
Thérapie 1992;47(5):445-6.
-
1992: Lapeyre-Mestre M; Chave B; Rascol O; Senard J M; Lafont J; Montastruc J L
[Antiparkinsonian drug consumption in a University Hospital Center 1981-1990]
Thérapie 1992;47(5):444-5.
-
1992: Tavernier G; Damase-Michel C; Tran M A; Montastruc J L; Montastruc P
[Differential regulation of the release of norepinephrine and neuropeptide Y]
Archives des maladies du coeur et des vaisseaux 1992;85(8):1137-40.
-
1992: Damase-Michel C; Tavernier G; Llau M E; Chollet F; Sénard J M; Bagheri H; Tran M A; Houin G; Guiraud-Chaumeil B; Montastruc J L
[Is there any desensitization of presynaptic alpha 2-adrenergic receptors in hypertension? Experimental and clinical studies]
Archives des maladies du coeur et des vaisseaux 1992;85(8):1149-51.
-
1992: Galinier M; Sénard J M; Dréan G; Valet P; Glock Y; Dalous P; Roux D; Puel J; Montastruc J L; Bounhoure J P
[Myocardial beta-adrenergic receptors and left ventricular hypertrophy induced by pressure overload in man]
Archives des maladies du coeur et des vaisseaux 1992;85(8):1113-7.
-
1992: Sénard J M; Galinier M; Valet P; Dréan G; Arias A; Tran M A; Montastruc J L; Montastruc P
[Beta adrenergic receptors and experimental left ventricular hypertrophy]
Archives des maladies du coeur et des vaisseaux 1992;85(8):1107-11.
-
1992: Montastruc J L; Rascol O; Senard J M; Rascol A
A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1992;55(7):630-1.
-
1992: Berlan M; Montastruc J L; Lafontan M
Pharmacological prospects for alpha 2-adrenoceptor antagonist therapy.
Trends in pharmacological sciences 1992;13(7):277-82.
-
1992: Durrieu G; LLau M E; Rascol O; Senard J M; Rascol A; Montastruc J L
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1992;2(3):153-7.
-
1992: Senard J M; Chamontin B; Rascol A; Montastruc J L
Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1992;2(2):99-104.
-
1992: Tavernier G; Damase-Michel C; Portolan G; Tran M A; Montastruc J L
Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation?
Naunyn-Schmiedeberg's archives of pharmacology 1992;345(4):431-6.
-
1992: Montastruc J L; Senard J M
[Calcium channel blockers and prevention of migraine]
Pathologie-biologie 1992;40(4):381-8.
-
1992: Montastruc P; Damase-Michel C; Tavernier G; Tran M A; Montastruc J L
Release of neuropeptide Y and noradrenaline during afferent nerve stimulation.
European journal of pharmacology 1992;213(1):159-62.
-
1992: Rascol O; Sabatini U; Chollet F; Celsis P; Montastruc J L; Marc-Vergnes J P; Rascol A
Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine.
Archives of neurology 1992;49(2):144-8.
-
1992: Galinier M; Sénard J M; Valet P; Dréan G; Planat V; Arias A; Tran M A; Montastruc J L
Myocardial hypertrophy, cardiac beta-adrenoceptors and adenylate cyclase activity during sinoaortic denervation in dogs.
British journal of pharmacology 1992;105(2):341-6.
-
1992: Poncet M F; Damase-Michel C; Tavernier G; Tran M A; Berlan M; Montastruc J L; Montastruc P
Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs.
British journal of pharmacology 1992;105(1):181-3.
-
1992: Lapeyre-Mestre M; Chave B; Montastruc J L
[Development of antibiotic consumption at the Regional University Hospital Center of Toulouse from 1980 to 1989]
Thérapie 1992;47(1):57-61.
-
1992: Lafontan M; Berlan M; Galitzky J; Montastruc J L
Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies.
The American journal of clinical nutrition 1992;55(1 Suppl):219S-227S.
-
1992: Bagheri H; Bompart G; Girolami J P; Montastruc J L; Montastruc P
Is yohimbine-induced increase in salivary secretion a kinin-dependent mechanism?
Fundamental & clinical pharmacology 1992;6(1):17-20.
-
1992: Montastruc J L; Charlet J P
Use of benzodiazepines and industrial injuries. Service Medical Interentreprises de Toulouse, France.
European journal of clinical pharmacology 1992;42(5):553-4.
-
1991: Sié P; Camez A; Derobert E; Rascol O; Montastruc J L; Boneu B
Locally activated coagulation induced by a peripheral endovenous catheter.
Thrombosis research 1991;64(6):775-82.
-
1991: Montastruc J L; Rascol O; Senard J M; Gualano V; Bagheri H; Houin G; Lees A; Rascol A
Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.
Clinical neuropharmacology 1991;14(5):432-7.
-
1991: Agniel A; Celsis P; Viallard G; Montastruc J L; Rascol O; Demonet J F; Marc-Vergnes J P; Rascol A
Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries.
Journal of neurology, neurosurgery, and psychiatry 1991;54(9):783-6.
-
1991: Sorbette F; Delay M; Genestal M; Jorda M F; Carrie D; Montastruc J L; Catala B; Bernadet P
[Cardio-circulatory arrest with mifepristone sulprostone combination for pregnancy interruption]
Thérapie 1991;46(5):387-9.
-
1991: Portillo M; Reverte M; Langin D; Senard J M; Tran M A; Berlan M; Montastruc J L
Effect of a 7-day treatment with idazoxan and its 2-methoxy derivative RX 821002 [correction of RX 821001] on alpha 2-adrenoceptors and non-adrenoceptor idazoxan binding sites in rabbits.
British journal of pharmacology 1991;104(1):190-4.
-
1991: Damase-Michel C; Schmitt L; Le Quang B; Bagheri H; Montastruc J L; Moron P
Plasma dopamine-beta-hydroxylase activity in depressed patients: role of treatment.
Journal of neurology, neurosurgery, and psychiatry 1991;54(8):749.
-
1991: Sabatini U; Rascol O; Celsis P; Houin G; Rascol A; Marc-Vergnes J P; Montastruc J L
Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.
British journal of clinical pharmacology 1991;32(2):229-34.
-
1991: Cadroy Y; Pourrat J; Baladre M F; Saivin S; Houin G; Montastruc J L; Vernier I; Boneu B
Delayed elimination of enoxaparin in patients with chronic renal insufficiency.
Thrombosis research 1991;63(3):385-90.
-
1991: Poncet M F; Tavernier G; Damase-Michel C; Tran M A; Berlan M; Montastruc J L; Montastruc P
[Neuropeptide Y, orthosympathetic nervous system, hypertension and alpha-2 adrenergic receptors]
Archives des maladies du coeur et des vaisseaux 1991;84(8):1239-41.
-
1991: Damase-Michel C; Durrieu G; Girolami J P; Moatti J P; Tran M A; Montastruc J L; Montastruc P
[Renal adrenergic beta receptors and experimental neurogenic hypertension]
Archives des maladies du coeur et des vaisseaux 1991;84(8):1163-6.
-
1991: Rascol O; Sabatini U; Simonetta-Moreau M; Montastruc J L; Rascol A; Clanet M
Square wave jerks in parkinsonian syndromes.
Journal of neurology, neurosurgery, and psychiatry 1991;54(7):599-602.
-
1991: Montastruc J L
Recent advances in the clinical pharmacology of Parkinson's disease.
Thérapie 1991;46(4):293-303.
-
1991: Montastruc J L
[Serotonin and migraine. Hypothesis with pathogenic and pharmacological implications]
La Revue du praticien 1991;41(14):1281-4.
-
1991: Peyret J; Montastruc J L; Montastruc P
[Drug consumption in sports and school medicine]
Thérapie 1991;46(3):255-6.
-
1991: Durrieu G; Senard J M; Tran M A; Rascol A; Montastruc J L
Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
Clinical neuropharmacology 1991;14(1):84-90.
-
1991: Girolami J P; Bascands J L; Pécher C; Berlan M; Montastruc J L; Montastruc P
Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for alpha 2-adrenoceptor-mediated inhibition of cholinergic pathways.
British journal of pharmacology 1991;102(2):351-4.
-
1991: Lapeyre-Mestre M; Lebret-Bories E; Charlet J P; Montastruc J L; Montastruc P
[Consumption of drugs in a population of school age subjects]
Thérapie 1991;46(1):49-53.
-
1991: Rolland F; Lafont J; Montastruc J L; Montastruc P
[Development of antihypertensive drug consumption in the Toulouse University Regional Hospital Center from 1981 to 1989]
Thérapie 1991;46(1):45-8.
-
1991: Poncet M F; Damase-Michel C; Valet P; Tran M A; Montastruc J L; Montastruc P
Clonidine but not propranolol decreases plasma neuropeptide Y (NPY) levels.
Fundamental & clinical pharmacology 1991;5(6):473-80.
-
1991: Damase-Michel C; Girolami J P; Bascands J L; Tran M A; Moatti J P; Pecher C; Berthet P; Tarrade T; Montastruc J L
Effects of cicletanine on vasoactive systems in conscious sinoaortic-denervated dogs.
Fundamental & clinical pharmacology 1991;5(8):719-32.
-
1991: Senard J M; Arias A; Berlan M; Tran M A; Rascol A; Montastruc J L
Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case report.
European journal of clinical pharmacology 1991;41(6):593-6.
-
1991: Senard J M; Durrieu G; Berlan M; Estan L; Valet P; Tran M A; Garrigues M; Montastruc J L
Absence of arterial hypertension despite chronic plasma noradrenaline elevation: evidence for down-regulation of alpha-adrenoceptors. A case report.
Fundamental & clinical pharmacology 1991;5(4):291-8.
-
1990: Durrieu G; Rispail Y; Chatelut E; Berlan M; Rascol A; Montastruc J L; Montastruc P
Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.
Clinical neuropharmacology 1990;13(6):492-9.
-
1990: Senard J M; Valet P; Durrieu G; Berlan M; Tran M A; Montastruc J L; Rascol A; Montastruc P
Adrenergic supersensitivity in parkinsonians with orthostatic hypotension.
European journal of clinical investigation 1990;20(6):613-9.
-
1990: Montastruc P; Colomes M; Calot J P; Montalegre J; Montastruc J L; Morere D; Napoleon M T
[Consumption of drugs by a blood donor population]
Thérapie 1990;45(6):515-6.
-
1990: Montastruc J L
[Parkinsonian syndrome. Etiology, diagnosis, treatment]
La Revue du praticien 1990;40(27):2555-9.
-
1990: Estan L; Senard J M; Tran M A; Montastruc J L; Berlan M
Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dog.
British journal of pharmacology 1990;101(2):329-36.
-
1990: Gimenez S; Bagheri H; Marchou B; Massip P; Lafont J; Sorbette F; Armengaud M; Montastruc J L
[Evaluation of the pharmacovigilance follow-up of zidovudine]
Thérapie 1990;45(5):407-9.
-
1990: Damase-Michel C; Montastruc J L; Tran M A; Gharib C; Geelen G; Montastruc P
Involvement of vasopressin in the cardiovascular effects of quinpirole.
European journal of pharmacology 1990;184(1):179-83.
-
1990: Galitzky J; Senard J M; Lafontan M; Stillings M; Montastruc J L; Berlan M
Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
British journal of pharmacology 1990;100(4):862-6.
-
1990: Rascol O; Senard J M; Rascol A; Montastruc J L
Apomorphine test in parkinsonian syndromes.
Lancet 1990;336(8713):518.
-
1990: Senard J M; Barbe P; Estan L; Guimbaud R; Louvet J P; Berlan M; Tran M A; Montastruc J L
Decreased high affinity state in platelet alpha 2-adrenoceptors from diabetic patients with orthostatic hypotension.
The Journal of clinical endocrinology and metabolism 1990;71(2):311-7.
-
1990: Colomes M; Rispail Y; Berlan M; Pous J; Montastruc J L
[Drug consumption in a retired population]
Thérapie 1990;45(4):321-4.
-
1990: Bagheri H; Berlan M; Montastruc J L; Montastruc P
Yohimbine and lacrimal secretion.
British journal of clinical pharmacology 1990;30(1):151-2.
-
1990: Barbe P; Senard J M; Estan L; Berlan M; Tran M A; Louvet J P; Montastruc J L
[Platelet alpha 2 adrenergic receptors, plasma catecholamines and orthostatic hypotension in insulin-dependent diabetic patients]
Archives des maladies du coeur et des vaisseaux 1990;83(8):1245-8.
-
1990: Durrieu G; Valet P; Berlan M; Villeneuve A; Montastruc J L
Levodopa up-regulates platelet alpha 2-adrenoceptors.
European journal of pharmacology 1990;182(3):597-601.
-
1990: Rascol O; Montastruc J L; Gauquelin G; Tran M A; Geelen G; Gharib C; Montastruc P
Cardiovascular effects of central injection of acetylcholine in anaesthetized dogs: a role for vasopressin release.
British journal of pharmacology 1990;100(3):471-6.
-
1990: Sabatini U; Rascol O; Rascol A; Montastruc J L
Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patients.
Clinical neuropharmacology 1990;13(3):264-7.
-
1990: Durrieu G; Senard J M; Rascol O; Tran M A; Lataste X; Rascol A; Montastruc J L
Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).
Neurology 1990;40(4):707-9.
-
1990: Senard J M; Colomes M; Rostin M; Clanet M; Montastruc J L
[Extrapyramidal syndromes caused by flunarizine. Apropos of 6 cases]
Thérapie 1990;45(2):157-9.
-
1990: Damase-Michel C; Montastruc J L; Gharib C; Geelen G; De Saint-Blanquat G; Tran M A
Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.
The Journal of pharmacology and experimental therapeutics 1990;252(2):770-7.
-
1990: Belin J; Montastruc J L; Montastruc P
[Drug prescription and drug monitoring in crenotherapy]
Thérapie 1990;45(1):51-2.
-
1990: Valet P; Berlan M; Beauville M; Crampes F; Montastruc J L; Lafontan M
Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
The Journal of clinical investigation 1990;85(1):291-5.
-
1990: Rascol O; Salachas F; Montastruc J L
[Neuroleptic malignant-like syndrome following levodopa withdrawal]
Revue neurologique 1990;146(3):215-8.
-
1990: Montastruc J L; Rascol O; Rascol A
[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study]
Revue neurologique 1990;146(2):144-7.
-
1990: Rostin M; Montastruc J L; Houin G; D'Azemar P; Bayrou B; Boneu B
Pharmacodynamics of CY 216 in healthy volunteers: inter-individual variations.
Fundamental & clinical pharmacology 1990;4(1):17-23.
-
1990: Rispail Y; Schmitt L; Berlan M; Montastruc J L; Montastruc P
Yohimbine increases salivary secretion in depressed patients treated with tricyclic antidepressants.
European journal of clinical pharmacology 1990;39(4):425-6.
-
1990: Galitzky J; Rivière D; Tran M A; Montastruc J L; Berlan M
Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers.
European journal of clinical pharmacology 1990;39(5):447-51.
-
1989: Lees A J; Montastruc J L; Turjanski N; Rascol O; Kleedorfer B; Peyro Saint-Paul H; Stern G M; Rascol A
Sublingual apomorphine and Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1989;52(12):1440.
-
1989: Montastruc J L; Macquin-Mavier I; Damase-Michel C; Dard B; Tran M A; Valet P
[Current data on the pharmacology of rilmenidine]
Archives des maladies du coeur et des vaisseaux 1989;82 Spec No 5():25-9.
-
1989: Damase-Michel C; Tran M A; Berthet P; Tarrade T; Montastruc J L
[Cicletanine and the sympathetic nervous system. A study of awake sino-aortic denervated hypertensive dogs]
Archives des maladies du coeur et des vaisseaux 1989;82 Spec No 4():55-8.
-
1989: Rascol O; Clanet M; Montastruc J L; Simonetta M; Soulier-Esteve M J; Doyon B; Rascol A
Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems.
Brain : a journal of neurology 1989;112 ( Pt 5)():1193-214.
-
1989: Dol F; Houin G; Rostin M; Montastruc J L; Dupouy D; Gianese F; Sie P; Boneu B
Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans.
Blood 1989;74(5):1577-82.
-
1989: Montastruc P; Berlan M; Montastruc J L
Effects of yohimbine on submaxillary salivation in dogs.
British journal of pharmacology 1989;98(1):101-4.
-
1989: Chatelut E; Rispail Y; Berlan M; Montastruc J L
Yohimbine increases human salivary secretion.
British journal of clinical pharmacology 1989;28(3):366-8.
-
1989: Galinier M; Senard J M; Valet P; Boneu B; Galinier F; Montastruc J L
Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivo.
Archives internationales de pharmacodynamie et de thérapie 1989;301():30-9.
-
1989: Montastruc J L; Macquin-Mavier I; Tran M A; Damase-Michel C; Koenig-Berard E; Valet P
Recent advances in the pharmacology of rilmenidine.
The American journal of medicine 1989;87(3C):14S-17S.
-
1989: Estan L; Montastruc J L; Montastruc P
Effect of nicardipine and BAY K-8644 on the pressor responses to afferent nervous stimulation in dogs.
Archives internationales de pharmacodynamie et de thérapie 1989;301():246-53.
-
1989: Montastruc P; Damase-Michel C; Montastruc J L
Apomorphine potentiates vagal bradycardia.
European journal of pharmacology 1989;166(3):511-4.
-
1989: Damase-Michel C; Tran M A; Montastruc J L; Moatti J P; Montastruc P
Effects of pinacidil on the sympatho-adrenal system in dogs.
British journal of pharmacology 1989;97(4):1019-26.
-
1989: Celsis P; Montastruc J L; Rascol O; Senard J M; Marc-Vergnes J P; Rascol A
Effect of tropatepine, an anticholinergic drug, on regional cerebral blood flow in patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1989;52(7):917-8.
-
1989: Senard J M; Valet P; Galinier M; Tran M A; Galinier F; Boneu B; Montastruc J L
[Alpha 2-adrenergic receptors and arterial pressure]
Archives des maladies du coeur et des vaisseaux 1989;82(7):1139-41.
-
1989: Chamontin B; Senard J M; Amar J; Doazan J P; Guittard J; Montastruc J L; Salvador M
[Neurogenic arterial hypertension in humans]
Archives des maladies du coeur et des vaisseaux 1989;82(7):1143-6.
-
1989: Montastruc J L; Rascol O; Rascol A
A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.
Journal of neurology, neurosurgery, and psychiatry 1989;52(6):773-5.
-
1989: Damase-Michel C; Tran M A; Montastruc J L
Effects of verapamil on sympathetic tone in normal and chronic sinoaortic-denervated conscious dogs.
Canadian journal of physiology and pharmacology 1989;67(5):428-30.
-
1989: Richer C; Decker N; Belin J; Imbs J L; Montastruc J L; Giudicelli J F
Odorous urine in man after asparagus.
British journal of clinical pharmacology 1989;27(5):640-1.
-
1989: Berlan M; Rascol O; Belin J; Moatti J P; Rascol A; Montastruc J L
Alpha 2-adrenergic sensitivity in Parkinson's disease.
Clinical neuropharmacology 1989;12(2):138-44.
-
1989: Valet P; Montastruc J L; Berlan M; Tran M A; Lafontan M; Montastruc P
Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog.
The Journal of pharmacology and experimental therapeutics 1989;249(1):271-7.
-
1989: Rascol O; Squalli A; Montastruc J L; Garat A; Houin G; Lachau S; Tor J; Blehaut H; Rascol A
A pilot study of stiripentol, a new anticonvulsant drug, in complex partial seizures uncontrolled by carbamazepine.
Clinical neuropharmacology 1989;12(2):119-23.
-
1989: Rascol A; Montastruc J L; Rascol O
[Antiparkinsonian drugs]
La Revue du praticien 1989;39(8):663-9.
-
1989: Montastruc J L; Damase-Michel C; Dang-Tran L; Montastruc P
Effects of four calcium channel blockers on central cardiovascular control.
Archives internationales de pharmacodynamie et de thérapie 1989;297():112-9.
-
1989: Valet P; Damase-Michel C; Montastruc J L; Montastruc P
Plasma catecholamines and adrenoceptors after chronic sinoaortic denervation in dogs.
Fundamental & clinical pharmacology 1989;3(3):307-20.
-
1989: Rascol O; Clanet M; Montastruc J L
Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drug.
Fundamental & clinical pharmacology 1989;3 Suppl():79s-87s.
-
1989: Damase-Michel C; Montastruc J L; Montastruc P
Central cardiovascular actions of calcium channel antagonists in dogs.
Fundamental & clinical pharmacology 1989;3 Suppl():57s-64s.
-
1989: Valet P; Bascands J L; Pécher C; Moatti J P; Montastruc J L; Girolami J P
Urinary kallikrein excretion in neurogenic hypertension in the dogs: possible relationship between kallikrein excretion and catecholamines.
Advances in experimental medicine and biology 1989;247B():437-42.
-
1989: Valet P; Bascands J L; Pecher C; Cabos G; Moatti J P; Montastruc J L; Girolami J P
Urinary kallikrein excretion following chronic sinoaortic denervation in conscious dogs.
Clinical and experimental hypertension. Part A, Theory and practice 1989;11(2):215-31.
-
1989: Montastruc J L; Gaillard G; Rascol O; Tran M A; Montastruc P
Effect of apomorphine on adrenal medullary catecholamine levels.
Fundamental & clinical pharmacology 1989;3(6):665-70.
-
1988: Valet P; Tran M A; Damase-Michel C; de Saint-Blanquat G; Dang Tran L; Anglade F; Koenig-Berard E; Montastruc J L
Rilmenidine (S 3341) and the sympathoadrenal system: adrenoreceptors, plasma and adrenal catecholamines in dogs.
Journal of autonomic pharmacology 1988;8(4):319-26.
-
1988: Montastruc J L; Rascol O; Rascol A
[Bromocriptine versus levodopa in the early treatment of Parkinson's disease. 1st results after 2 years]
Thérapie 1988;43(6):461-3.
-
1988: Valet P; Damase-Michel C; Chamontin B; Durand D; Chollet F; Montastruc J L
Platelet alpha 2- and leucocyte beta 2-adrenoceptors in phaeochromocytoma: effect of tumour removal.
European journal of clinical investigation 1988;18(5):481-5.
-
1988: Rascol O; Montastruc J L; Senard J M; Demonet J F; Simonetta M; Rascol A
Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial.
Neurology 1988;38(9):1387-91.
-
1988: Cervera P; Rascol O; Ploska A; Gaillard G; Raisman R; Duyckaerts C; Hauw J J; Scherman D; Montastruc J L; Javoy-Agid F
Noradrenaline, adrenaline and tyrosine hydroxylase in adrenal medulla from parkinsonian patients.
Journal of neurology, neurosurgery, and psychiatry 1988;51(8):1104-5.
-
1988: Doursout M F; Chelly J E; Hartley C J; Szilagyi J; Montastruc J L; Buckley J P
Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
The Journal of pharmacology and experimental therapeutics 1988;246(2):591-6.
-
1988: Montastruc J L; Cathala B; Richard J P; Cotonat J; Charlet J P; Gabach P; Cabrera C
[Drugs and traffic accidents. Evaluation of a survey realized in a hospital environment]
Thérapie 1988;43(4):313-5.
-
1988: Valet P; Damase-Michel C; Gaillard G; Galinier M; Chamontin B; Cholet F; Durand D; Salvador M; Barthe P; Montastruc J L
[Value of the study of circulating adrenergic receptors in the diagnosis and surveillance after surgery of pheochromocytoma]
Archives des maladies du coeur et des vaisseaux 1988;81 Spec No():109-12.
-
1988: Rostin M; Douste-Blazy P; Galinier M; Montastruc J L
[Lithium and the converting enzyme inhibitor: a dangerous combination]
Presse médicale (Paris, France : 1983) 1988;17(23):1218.
-
1988: Rostin M; Montastruc J L; Guiraud-Chaumeil B; Rascol A
[Outcome of an extrapyramidal syndrome during prophylactic treatment of migraine with flunarizine]
Thérapie 1988;43(3):242.
-
1988: Marc-Vergnes J P; Celsis P; Montastruc J L; Demonet J F; Agniel A; Rascol O; Viallard G; Doyon B; Rascol A
[Cerebral hemodynamics and clinical pharmacology in Parkinson disease]
Thérapie 1988;43(2):83-8.
-
1988: Tran M A; De Saint-Blanquat G; Valet P; Tran L D; Anglade F; Gaillard G; Rascol O; Brisac A M; Montastruc J L; Montastruc P
Is adrenal medulla involved in the antihypertensive effect of nicardipine?
The Journal of pharmacology and experimental therapeutics 1988;244(3):1116-20.
-
1988: Celsis P; Rascol O; Demonet J F; Agniel A; Montastruc J L; Marc-Vergnes J P; Rascol A
[Effect of bromocriptine on cerebral blood flow in Parkinson's disease]
Revue neurologique 1988;144(5):367-71.
-
1988: Valet P; Damase-Michel C; Taouis M; Montastruc J L; Cotonat J; Montastruc P
Acute release of catecholamines on circulating blood cell adrenoceptors and metabolic indices in dog.
Fundamental & clinical pharmacology 1988;2(4):267-76.
-
1987: Rascol O; Tran M A; Bonnevialle P; Belin J; Cotonat J; Guiraud-Chaumeil B; Montastruc J L
Lack of correlation between plasma levels of amitriptyline (and nortriptyline) and clinical improvement of chronic pain of peripheral neurologic origin.
Clinical neuropharmacology 1987;10(6):560-4.
-
1987: Brisac A M; Huguet F; Champeroux P; Montastruc J L; Lucet B; Gerard P; Laurent S; Narcisse G; Schmitt H
Central interactions between dihydropyridines and cholinergic systems in the control of blood pressure in rat.
Brain research 1987;435(1-2):160-6.
-
1987: Fournie B; Montastruc J L; Rostin M; Baro J P; Bastide G; Fournie A
[Vascular ergotism. Acute ischemia of the lower limb during oral treatment with methylergometrin]
Presse médicale (Paris, France : 1983) 1987;16(37):1865.
-
1987: Damase-Michel C; Valet P; Montastruc J L
Nicardipine causes sympathetic activation that does not involve baroreceptor reflex tachycardia in conscious sinoaortic-denervated dogs.
European journal of pharmacology 1987;142(1):145-9.
-
1987: Gaillard G; Rascol O; Montastruc J L
Adrenal catecholamine concentration after domperidone.
Clinical neuropharmacology 1987;10(5):479-81.
-
1987: Montastruc J L; Dang Tran L; Huchet-Brisac A M; Chelly J; Rostin M; Montastruc P
Involvement of cholinergic mechanisms in the central cardiovascular actions of nicardipine in dogs.
Archives internationales de pharmacodynamie et de thérapie 1987;289(2):212-6.
-
1987: Montastruc J L; Rascol O; Belin J; Ane M; Rascol A
Does papaverine interact with levodopa in Parkinson's disease?
Annals of neurology 1987;22(4):558-9.
-
1987: Bourgoin S; Cesselin F; Gozlan H; Fattaccini C M; Tran M A; Montastruc J L; Rascol A; Hamon M
Chronic chlorimipramine does not reverse the reduction of cerebrospinal fluid Met-enkephalin-like immunoreactivity in chronic-pain patients.
Clinical neuropharmacology 1987;10(5):434-42.
-
1987: Valet P; Damase-Michel C; Chamontin B; Durand D; Gaillard G; Salvador M; Montastruc J L
Adrenoceptors in the diagnosis of phaeochromocytoma.
Lancet 1987;2(8554):337.
-
1987: Anglade F; Dang Tran L; De Saint Blanquat G; Gaillard G; Michel-Damase C; Montastruc J L; Montastruc P; Rostin M; Tran M A
A study of the action of clonidine on secretion from the adrenal medulla in dogs.
British journal of pharmacology 1987;91(3):481-6.
-
1987: Rostin M; Pascaud A; Lauque D; Sorbette F; Carles P; Montastruc J L
[An intensive survey of drug surveillance in a medical admissions department]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1987;8(2):173-9.
-
1987: Rostin M; Montastruc J L; Senard J M; Chamontin B; Montastruc P
[Clinical pharmacology and bases of the treatment of orthostatic hypotension]
Thérapie 1987;42(1):41-4.
-
1987: Simonetta M; Schmitt L; Montastruc J L; Rascol A
[Neuropsychic side effects of bromocriptine in Parkinson's disease]
Revue neurologique 1987;143(8-9):608-11.
-
1987: Campistron G; Rostin M; Coulais Y; Caillard C; Zarrouk G; Frances J; Thiercellin J F; Montastruc J L; Houin G
Effect of size and dosage strength on the bioavailability of two diltiazem formulations during repeated administrations in humans.
Fundamental & clinical pharmacology 1987;1(1):67-75.
-
1987: Montastruc J L; Celsis P; Agniel A; Demonet J F; Doyon B; Puel M; Marc-Vergnes J P; Rascol A
Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.
Movement disorders : official journal of the Movement Disorder Society 1987;2(4):279-89.
-
1987: Montastruc P; Valet P; Dang Tran L; Gaillard G; Montastruc J L
Effects of calcium entry blockers on blood pressure and heart rate in neurogenic hypertensive dogs.
Fundamental & clinical pharmacology 1987;1(2):85-94.
-
1987: Begaud B; Dang Tran L; Montastruc J L; Montastruc P
Antihypertensive effects of mesulergine: further evidence for a peripheral site of action of dopamine agonists.
Fundamental & clinical pharmacology 1987;1(3):153-9.
-
1987: Montastruc J L; Chamontin B; Rostin M; Rascol O; Valet P; Gaillard G; Tran M A; Van T T; Ader J L; Montastruc P
Experimental and clinical approaches to treatment of hypertension by dopamine receptor agonists.
Clinical and experimental hypertension. Part A, Theory and practice 1987;9(5-6):1069-84.
-
1987: Montastruc J L; Villeneuve A; Berlan M; Lafontan M; Caranobe C; Boneu B; Rascol A
Study of platelet alpha 2-adrenoceptors in Parkinson's disease.
Advances in neurology 1987;45():253-8.
-
1987: Gaillard G; Tran M A; Rostin M; Salvayre R; Montastruc J L
Effect of clonidine on adrenal medulla catecholamine levels in rats.
Fundamental & clinical pharmacology 1987;1(1):1-5.
-
1987: Chamontin B F; Montastruc J L; Salvador M J
Hypertension with orthostatic hypotension: interest of verapamil.
Journal of cardiovascular pharmacology 1987;10 Suppl 10():S114-6.
-
1986: Douste-Blazy P; Blanc M; Montastruc J L; Conte D; Cotonat J; Galinier F
Is there any interaction between digoxin and enalapril?
British journal of clinical pharmacology 1986;22(6):752-3.
-
1986: Devynck M A; Rostin M; David-Dufilho M; Montastruc J L
[Neurohumoral factors and the vasomotor system]
Archives des maladies du coeur et des vaisseaux 1986;79(12):1824-6.
-
1986: Villeneuve A; Berlan M; Paris H; Tran M A; Lafontan M; Montastruc J L; Montastruc P
Effect of clomipramine treatment on dog platelet alpha 2-adrenergic receptivity.
Journal de pharmacologie 1986;17(4):644-50.
-
1986: Michel C; Montastruc J L; Valdiguié P; Montastruc P
Effects of morphine on urine flow in rats. Involvement of vasopressin.
Journal de pharmacologie 1986;17(3):316-22.
-
1986: Rostin M; Montastruc J L; Sorbette F; Leophonte P; Montastruc P
[Respiratory complications of drugs used in neurology and psychiatry]
Thérapie 1986;41(4):263-7.
-
1986: Douste-Blazy P; Rostin M; Livarek B; Tordjman E; Montastruc J L; Galinier F
Angiotensin converting enzyme inhibitors and lithium treatment.
Lancet 1986;1(8495):1448.
-
1986: Chamontin B; Villeneuve A; Berlan M; Montastruc J L; Salvador M
[Arterial hypertension with orthostatic hypotension caused by dysregulation of the baroreflex. Correction with domperidone and verapamil]
Presse médicale (Paris, France : 1983) 1986;15(12):581.
-
1986: Rascol A; Montastruc J L; Rascol O
Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine.
Headache 1986;26(2):83-5.
-
1986: Mouysset B; Montastruc J L; Rostin M; Caratero A; Sorbette F; Leophonte P; Rascol A
[Bromocriptine and pleuropulmonary fibrosis]
Thérapie 1986;41(1):75.
-
1986: Rascol O J; Montastruc J L
Cardiovascular effects of apomorphine in humans: evidence for peripheral mechanisms.
Clinical neuropharmacology 1986;9(6):566-9.
-
1986: Demonet J F; Rostin M; Dueymes J M; Ioualalen A; Montastruc J L; Rascol A
Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine.
Clinical neuropharmacology 1986;9(2):200-1.
-
1986: Rascol A; Montastruc J L; Rascol O; Senard J M
Mesulergine (CU 32-085) in the treatment of Parkinson's disease.
Clinical neuropharmacology 1986;9(2):146-52.
-
1985: Villeneuve A; Berlan M; Lafontan M; Caranobe C; Boneu B; Rascol A; Montastruc J L
Platelet alpha 2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment.
European journal of clinical investigation 1985;15(6):403-7.
-
1985: Montastruc P; Dang-Tran L; Carvajal A; Rostin M; Montastruc J L
Naloxone reverses the effects of enalapril and enalaprilic acid on the pressor responses to afferent vagal stimulation.
Neuropeptides 1985;6(6):537-42.
-
1985: Montastruc P; Dang Tran L; Montastruc J L
Reduction of vagal pressor reflexes by neurohypophyseal peptides and related compounds.
European journal of pharmacology 1985;117(3):355-61.
-
1985: Montastruc J L; Chamontin B; Rascol A
Parkinson's disease and hypertension: chronic bromocriptine treatment.
Neurology 1985;35(11):1644-7.
-
1985: Montastruc J L; Rostin M; Lhoste F; Gaillard-Plaza G; Montastruc P
[Role of the adrenal medulla in the effect of antihypertensive drugs]
Archives des maladies du coeur et des vaisseaux 1985;78(11):1647-51.
-
1985: Montastruc J L; Guiol C; Tran M A; Lhoste F; Montastruc P
Studies on the cardiovascular actions of apomorphine in dogs: central versus peripheral mechanisms and role of the adrenal medulla.
Archives internationales de pharmacodynamie et de thérapie 1985;277(1):92-103.
-
1985: Montastruc J L; David J; Rascol A
Does the piribedil test permit predicting the efficacy of domperidone, a dopaminergic antagonist, in the treatment of migraine?
Headache 1985;25(6):332-3.
-
1985: Montastruc J L; Richard J P; Cathala B
Naloxone fails to reverse blood pressure in shock: a double blind study in man.
Journal de pharmacologie 1985;16(3):313-4.
-
1985: Reichenberg K; Gaillard-Plaza G; Montastruc J L
Influence of naloxone on the antinociceptive effects of some antidepressant drugs.
Archives internationales de pharmacodynamie et de thérapie 1985;275(1):78-85.
-
1985: Montastruc J L; Rostin M; Montastruc P
[Peripheral autonomic (nonrespiratory) effects of the stimulation of posterior cerebral fossa structures: neurophysiological and neuropharmacological aspects]
Agressologie: revue internationale de physio-biologie et de pharmacologie appliquées aux effets de l'agression 1985;26(5):419-22.
-
1985: Auriac A; Azam J; Dumas J C; Roux G; Montastruc J L
[Changes in water metabolism in rats under the influence of naloxone: role of vasopressin]
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1985;39(2):94-8.
-
1985: Montastruc J L; Chamontin B; Senard J M; Rascol A
Domperidone in the management of orthostatic hypotension.
Clinical neuropharmacology 1985;8(2):191-2.
-
1985: Montastruc J L; Tran M A; Blanc M; Charlet J P; David J; Mansat M; Cotonat J; Patacq-Sapijanskas M; Guiraud-Chaumeil B; Rascol A
Measurement of plasma levels of clomipramine in the treatment of chronic pain.
Clinical neuropharmacology 1985;8(1):78-82.
-
1985: Montastruc J L; Tran M A; Guiol C; Blanc M; Gaillard G; Cotonat J; Montastruc P
[Effects of a morphine-clomipramine combination on a test of experimental analgesia]
Revue neurologique 1985;141(10):669-71.
-
1985: Villeneuve A; Berlan M; Lafontan M; Montastruc J L
Characterization of dog platelet alpha-adrenergic receptor: lack of in vivo down regulation by adrenergic agonist treatments.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1985;81(1):181-7.
-
1984: Montastruc P; Montastruc J L; Gaillard-Plaza G
Influence of methyldopa and bromocriptine on negative pressure breathing-induced diuresis.
Journal de pharmacologie 1984;15(4):415-20.
-
1984: Montastruc J L; Guiol C
[Experimental study of the hypotensive effect of apomorphine]
Archives des maladies du coeur et des vaisseaux 1984;77(11):1176-80.
-
1984: Montastruc P; Montastruc J L; Gaillard-Plaza G
Influence of naloxone on the captopril-induced decrease in vagal pressor reflexes.
Journal de pharmacologie 1984;15(4):421-6.
-
1984: Montastruc J L; Rascol A
[Treatment of Parkinson's disease with high doses of bromocriptine. Possible interaction with josamycin]
Presse médicale (Paris, France : 1983) 1984;13(37):2267-8.
-
1984: Chamontin B; Montastruc J L; Rascol A
[How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution]
Archives des maladies du coeur et des vaisseaux 1984;77(11):1181-5.
-
1984: Montastruc J L; Dang Tran L
The role of adrenal medulla and neurohypophysis in the central and peripheral cardiovascular effects of neurohypophysial peptides.
Archives internationales de pharmacodynamie et de thérapie 1984;270(2):299-308.
-
1984: Cesselin F; Bourgoin S; Hamon M; Artaud F; Testut M F; Rascol A; Montastruc J L
Normal CSF levels of met-enkephalin-like material in a case of naloxone-reversible congenital insensitivity to pain.
Neuropeptides 1984;4(3):217-25.
-
1984: Montastruc J L; Gaillard-Plaza G; Montastruc P
Influence of bromocriptine on the pressor responses to afferent nervous stimulation.
Journal de pharmacologie 1984;15(2):169-76.
-
1984: Douste-Blazy P; Montastruc J L; Bonnet B; Auriol P; Conte D; Bernadet P
Influence of amiodarone on plasma and urine digoxin concentrations.
Lancet 1984;1(8382):905.
-
1984: Rascol A; Montastruc J L; Rascol O
Should dopamine agonists be given early or late in the treatment of Parkinson's disease?
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1984;11(1 Suppl):229-32.
-
1984: Guiol C; Montastruc J L; Montastruc P
Naloxone reduces diuretic responses induced by water, alcohol or congenital lack of vasopressin in rats.
British journal of pharmacology 1984;81(1):85-90.
-
1984: Montastruc J L; Dang Tran L
Neurohypophysial peptides and central cardiovascular control in the anaesthetized dog.
Clinical and experimental hypertension. Part A, Theory and practice 1984;6(10-11):1987-91.
-
1984: Guiol C; Tran M A; Blanc M; Charlet J P; Eschalier A; Cotonat J; Montastruc J L
Is there any relationship between antinociception, doses and plasma levels of clomipramine during subchronic treatment in rats?
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1984;38(1):59-62.
-
1984: Montastruc J L; Gaillard-Plaza G; Montastruc P
Naloxone suppresses the vasodepressor action of captopril in the anaesthetized dog.
Clinical and experimental hypertension. Part A, Theory and practice 1984;6(10-11):1825-8.
-
1983: Montastruc J L; Dang Tran L; Montastruc P
Neurohypophysial peptides and central cardiovascular control.
European heart journal 1983;4 Suppl G():47-50.
-
1983: Auriac A; Azam J; Dumas J C; Roux G; Montastruc J L
[Role of alpha 1 adrenergic receptors in water balance in the rat]
Journal de pharmacologie 1983;14(3):351-60.
-
1983: Calmels J P; Albarede J L; Sorbette F; Montastruc J L
[Drug-induced neuropsychic disorders in a hospital environment. Retrospective study during a 6-month period]
Thérapie 1983;38(3):325-6.
-
1983: Montastruc J L; Montastruc P
The role of the adrenal medulla in the antihypertensive action of bromocriptine in neurogenic hypertensive dogs.
Journal de pharmacologie 1983;14(2):183-7.
-
1983: Montastruc P; Montastruc J L
Effects of captopril on blood pressure in neurogenic hypertensive dogs.
Archivos de farmacología y toxicología 1983;9(1):47-52.
-
1983: Seigneuric C; Plantavid M; Sorbette F; Montastruc J L; Galley M; Heguy J
[Extrapyramidal syndrome. Possible role of metopimazine]
Presse médicale (Paris, France : 1983) 1983;12(15):962-3.
-
1983: Montastruc J L
[Morphine antagonists]
La Revue du praticien 1983;33(7):293-6 passim.
-
1983: Tran M A; Montastruc J L; Montastruc P
[Pharmacological basis for the therapeutic use of ergot alkaloids]
Presse médicale (Paris, France : 1983) 1983;12(8):517-20.
-
1983: Gaillard-Plaza G; Lopez-Timoneda F; Montastruc J L
[Endomorphins and experimental analgesic action of amitriptyline]
Revue neurologique 1983;139(8-9):529-30.
-
1983: Montastruc J L; Tran M A; Charlet J P; Gaillard-Plaza G; David J; Cotonat J; Guiraud B; Rascol A
[Analgesic properties and plasma concentrations of clomipramine in chronic pain]
Revue neurologique 1983;139(10):583-7.
-
1982: Montastruc J L; Montastruc P
Alpha-adrenolytic properties of bromocriptine in dogs.
Archives internationales de pharmacodynamie et de thérapie 1982;260(1):83-90.
-
1982: Guiol C; Montastruc J L
[Effect of clonidine on polyuria induced by alcohol, water or the lack of vasopressin in the rat]
Journal de pharmacologie 1982;13(4):565-72.
-
1982: Gaillard-Plaza G; Tran M A; Charlet J P; Cotonat J; Montastruc J L
Plasma levels and analgesic effects of clomipramine during acute treatment in rats.
Journal de pharmacologie 1982;13(4):509-13.
-
1982: Tran L D; Montastruc J L; Montastruc P
Effects of lysine-vasopressin and oxytocin on central cardiovascular control.
British journal of pharmacology 1982;77(1):69-73.
-
1982: Calmels J P; Sorbette F; Montastruc J L; Albarede J L
[Iatrogenic hyperkinetic syndrome caused by an antihistaminic]
La Nouvelle presse médicale 1982;11(30):2296-7.
-
1982: Montastruc J L; Montastruc P
Naloxone and acute neurogenic hypertension in anaesthetized dogs.
Archivos de farmacología y toxicología 1982;8(1):45-8.
-
1982: Montastruc P; Montastruc J L; Dang Tran L
Clonidine inhibits diuresis caused by negative pressure breathing and left atrial distension: role of central adrenergic alpha 2 receptors.
Journal de pharmacologie 1982;13(2):317-27.
-
1982: Montastruc P; Montastruc J L; Tran L D
Evidence for the involvement of central alpha 2 mechanisms in intrathoracic volume expansion--induced diuresis: a study with clonidine and propranolol.
Aviation, space, and environmental medicine 1982;53(4):347-53.
-
1982: Montastruc P; Faruch M; Montastruc J L
[Trial of vasopressin treatment of chronic alcoholism]
Thérapie 1982;37(1):103-5.
-
1982: Rascol A; Montastruc J L; Guiraud-Chaumeil B; Clanet M
[Bromocriptine as the 1st treatment of Parkinson's disease. Long term results]
Revue neurologique 1982;138(5):401-8.
-
1981: Montastruc P; Haddad C; El Zein S; Montastruc J L
[Effect of propranolol on basal oxygen consumption. Study in humans in respiratory arrest under general anesthesia or in a deep coma]
Thérapie 1981;36(6):697-700.
-
1981: Montastruc J L; Gaillard-Plaza G; Thomas J; Montastruc P
[Influence of nephrectomy on the antihypertensive effects of propranolol in the dog (author's transl)]
Journal de pharmacologie 1981;12(4):465-70.
-
1981: Montastruc J L; Morales-Olivas F; Montastruc P
Effects of adrenolytic drugs on the antihypertensive action of beta-blocking agents in the acute neurogenic hypertensive dog.
Journal de pharmacologie 1981;12(4):427-39.
-
1981: Tran L D; Montastruc J L; Montastruc P
[Demonstration of a central hypotensive action of lysine vasopressin in the dog]
Comptes rendus des séances de l'Académie des sciences. Série III, Sciences de la vie 1981;293(5):267-9.
-
1981: Montastruc J L; Montastruc P; Morales-Olivas F
Potentiation by naloxone of pressor reflexes.
British journal of pharmacology 1981;74(1):105-9.
-
1981: Rascol A; Clanet M; Montastruc J L; Delage W; Guiraud-Chaumeil B
L5H tryptophan in the cerebellar syndrome treatment.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1981;35(4):112-3.
-
1981: Montastruc J L; Montastruc P
Antihypertensive action of bromocriptine in neurogenic hypertensive dogs.
Archives internationales de pharmacodynamie et de thérapie 1981;252(2):210-8.
-
1981: Eschalier A; Montastruc J L; Devoize J L; Rigal F; Gaillard-Plaza G; Pechadre J C
Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats.
European journal of pharmacology 1981;74(1):1-7.
-
1981: Auriac A; Azam J; Dumas J C; Roux G; Montastruc J L
[Effects of clonidine on diuresis and water intake in normal and Brattleboro rats. (author's transl)]
Journal de pharmacologie 1981;12(3):277-88.
-
1981: Montastruc P; Montastruc J L; Tran L D
Blockade by clonidine of negative pressure breathing-induced diuresis in the dog.
European journal of pharmacology 1981;72(4):373-6.
-
1981: Montastruc J L; Rascol A; Montastruc P
[Hypotensive action of a dopaminergic agonist, bromocriptine, in the dog]
Archives des maladies du coeur et des vaisseaux 1981;74 Spec No():91-8.
-
1981: Montastruc J L; Puech A J; Clanet M; Guiraud-Chaumeil B; Rascol A
[Yohimbine in treatment of Parkinson's disease. Preliminary results (author's transl)]
La Nouvelle presse médicale 1981;10(16):1331-2.
-
1981: Montastruc J L; Montastruc P
Effect of intracisternal 5,-7-dihydroxytryptamine on the acute antihypertensive action of propranolol in the sino-aortic denervated anaesthetized dog.
British journal of pharmacology 1981;72(3):411-7.
-
1980: Montastruc J L; Morales-Olivas F; Montastruc P
Effect of morphine on diuresis in normal and diabetes insipidus dogs.
Archivos de farmacología y toxicología 1980;6(3):287-90.
-
1980: Montastruc J L; Dang Tran L; Castillo-Ferrando J R; Morales-Olivas F; Gaillard-Plaza G; Montastruc P
Effects of yohimbine and prazosin on water balance in dogs with diabetes insipidus.
Journal de pharmacologie 1980;11(4):441-8.
-
1980: Montastruc J L; Cotonat J; Rascol A
[On the potentiation of the effects of phenobarbital by dipropylacetic acid (author's transl)]
La Nouvelle presse médicale 1980;9(33):2350.
-
1980: Cesselin F; Montastruc J L; Gros C; Bourgoin S; Hamon M
Met-enkephalin levels and opiate receptors in the spinal cord of chronic suffering rats.
Brain research 1980;191(1):289-93.
-
1980: Montastruc J L; Montastruc P
Effect of intracisternal application of 6-hydroxydopamine on the antihypertensive action of propranolol in the dog.
European journal of pharmacology 1980;63(2-3):103-16.
-
1980: Soubrie P; Thiebot M H; Jobert A; Montastruc J L; Hery F; Hamon M
Decreased convulsant potency of picrotoxin and pentetrazol and enhanced [3H]flunitrazepam cortical binding following stressful manipulations in rats.
Brain research 1980;189(2):505-17.
-
1980: Montastruc J L; Montastruc P
Effect of intracisternal butoxamine, a beta-2 adrenoceptor blocking agent, on blood pressure and heart rate in the dog.
Archives internationales de pharmacodynamie et de thérapie 1980;243(1):132-8.
-
1980: Montastruc P; Montastruc J L
[Water intraportal infusion-induced diuresis: a comparative study in normal, hypophysectomized and adrenalectomized dogs (author's transl)]
Journal de physiologie 1980;76(1):79-82.
-
1979: Montastruc P; Montastruc J L
Comparative effect of isoprenaline, dopamine and angiotensin on drinking, diuresis and natriuresis in normal and diabetic insipidus dogs.
Archivos de farmacología y toxicología 1979;5(2):73-8.
-
1979: Montastruc J L; Montastruc P
[Can blockade of presynaptic adrenergic beta receptors explain the antihypertensive effects of propranolol?]
Comptes rendus des séances de l'Académie des sciences. Série D, Sciences naturelles 1979;289(1-2):37-40.
-
1979: Montastruc P; Moreno-González A; Montastruc J L
Effect of intravenous or intracisternal clonidine and propranolol on plasma renin. Activity in hypertensive dogs.
Archivos de farmacología y toxicología 1979;5(1):1-8.
-
1979: Rascol A; Guiraud B; Montastruc J L; David J; Clanet M
Long-term treatment of Parkinson's disease with bromocriptine.
Journal of neurology, neurosurgery, and psychiatry 1979;42(2):143-50.
-
1979: Montastruc J L; Montastruc P
Antihypertensive effects of intra-cisternal beta-blocking agents in dogs with acute nerogenic hypertension.
Archives internationales de pharmacodynamie et de thérapie 1979;237(2):275-81.
-
1978: Montastruc P; Moreno-González A; Montastruc J L
Experimental studies on the anti-hypertensive effect of acebutolol in dogs: further evidence for a central site of action.
Archivos de farmacología y toxicología 1978;4(3):293-304.
-
1978: Rascol A; Guiraud-Chaumeil B; Laboucarie J; Montastruc J L; El-Hage W
[Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus]
Thérapie 1978;33(5):623-8.
-
1978: Montastruc J L; Moreno-González A; Cotonat J
[Effect of chlorpromazine on hypertension by desinhibition in dogs: comparison of intravenous and intracisternal administration (author's transl)]
Archivos de farmacología y toxicología 1978;4(2):221-26.
-
1978: Montastruc J L; Cotonat J; Andrieu M
Effect of variations of blood pH on the haemodynamic actions of papaverine.
Archivos de farmacología y toxicología 1978;4(1):90-5.
-
1978: Montastruc P; Montastruc J L
[Central cardiovascular effect of isoprenaline and some adrenergic beta blocking agents in neurogenic hypertensive dog: role of central beta-adrenoceptors (author's transl)]
Journal de physiologie 1978;74(7):651-8.
-
1978: Montastruc J L; Moreno-Gonzalez A; Cotonat J
[Effects of chlorpromazine on hypertension by desinhibition in dogs: comparison of intravenous and intracisternal administration]
Comptes rendus des séances de la Société de biologie et de ses filiales 1978;172(5):978-82.
-
1978: Montastruc P; Montastruc J L; Moatti J P
[Effect of clonidine on three types of experimental hypertension and on plasma renin activity in dogs]
Comptes rendus des séances de la Société de biologie et de ses filiales 1978;172(1):200-7.
-
1977: Montastruc P; Montastruc J L; Moatti J
[Effects of propranolol in experimental arterial hypertension]
La Nouvelle presse médicale 1977;6(43):4072.
-
1977: Baisset A; Montastruc P; Montastruc J L; Fagot-Revurat P
[Influence of blood pH on pressor effec of dopamine]
Thérapie 1977;32(1):133-6.
Sign-in to see more